Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Hear Res. 2021 May 24;419:108278. doi: 10.1016/j.heares.2021.108278

Diverse identities and sites of action of cochlear neurotransmitters

Siân R Kitcher 1, Alia M Pederson 1, Catherine JC Weisz 1,*
PMCID: PMC8611113  NIHMSID: NIHMS1712087  PMID: 34108087

Abstract

Accurate encoding of acoustic stimuli requires temporally precise responses to sound integrated with cellular mechanisms that encode the complexity of stimuli over varying timescales and orders of magnitude of intensity. Sound in mammals is initially encoded in the cochlea, the peripheral hearing organ, which contains functionally specialized cells (including hair cells, afferent and efferent neurons, and a multitude of supporting cells) to allow faithful acoustic perception. To accomplish the demanding physiological requirements of hearing, the cochlea has developed synaptic arrangements that operate over different timescales, with varied strengths, and with the ability to adjust function in dynamic hearing conditions. Multiple neurotransmitters interact to support the precision and complexity of hearing. Here, we review the location of release, action, and function of neurotransmitters in the mammalian cochlea with an emphasis on recent work describing the complexity of signaling.

Introduction

Early studies of neurotransmitters in the cochlea relied predominantly on histological techniques to visualize the location of neurotransmitters, and so necessarily focused on cochlear anatomy. Advances in molecular biology techniques, genetic engineering, and physiological recordings have allowed a closer look not only at which transmitters are present in the cochlea, but also their functional roles. While up to 200 molecules can be classified as neurotransmitters (Svensson et al., 2018), here we consider molecules that have specifically been investigated in the cochlea in an update from previous, excellent reviews (Dulon et al., 2006; Eybalin, 1993; Sewell, 2011). We restrict the substances considered to those released in the cochlea with function on an acute timescale.

Glutamate

Rapid, excitatory neurotransmission throughout the central nervous system (CNS) is primarily mediated by glutamatergic signaling through ionotropic post-synaptic receptors of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic (AMPA), N-methyl-D-aspartate (NMDA), or kainate subtypes. Glutamatergic signaling generally evokes a fast (ms timescale kinetics), excitatory and depolarizing post-synaptic response, but it can also act through metabotropic receptors at pre- and post-synaptic sites with diverse downstream effects.

Glutamate release from IHCs

The inner hair cell (IHC) is the primary sensory receptor of the mammalian cochlea. It sends signals to the auditory centers of the brain through the type I spiral ganglion neurons (SGNs) of the auditory nerve (Figure 1A, B). Synapses between IHCs and type I SGNs are termed ribbon synapses after the electron dense structure, or ribbon, at the presynaptic active zone. The ribbon is associated with multivesicular release from IHCs to drive fast, large-amplitude, post-synaptic responses in type I SGNs (for review see Wichmann and Moser, 2015).

Figure 1:

Figure 1:

Glutamate signaling in the organ of Corti. A. Schematic of the developing IHC afferent signaling complex indicating localization to cochlear cells of vesicular glutamate and proton release, receptor subtypes, and membrane transporters. Note: localization of molecules to SGN somata not depicted. Synaptoplasmic cistern (grey elongated oval) depicted in the hair cell post-synaptic domain apposed to the MOC terminal. B. Schematic of the ~mature IHC afferent signaling complex with localization of glutamate signaling molecules as in ‘A’. C. Technique for whole-cell patch-clamp recordings from type I SGN afferent boutons. DIC image depicts the recording electrode (lower right) patched onto a type I SGN post-synaptic bouton apposed to an IHC (dashed outline). Blue box indicates region depicted in schematic (inset) of patch-clamp technique. D. Amplitude histogram of PSCs recorded from a type I SGN bouton, noise amplitude indicated in grey. Inset: Overlaid spontaneous PSC waveforms recorded from a single type I SGN afferent bouton, isolated trace (far left) shows a multi-phasic EPSC (C-D modified from Glowatzki and Fuchs 2002, Nature Neuroscience, with permission). E. Schematic of afferent signaling at the mature OHC synapse indicating localization to cochlear cells of vesicular glutamate and proton release and receptor subtypes. F. Amplitude histogram of PSCs recorded from a type II SGN dendrite. Inset shows 5 overlaid spontaneous PSCs. G. DIC images depicting type II SGN dendrite recording technique. Gi. DIC image of three rows of OHCs, stereocilia visible. Gii. Lower focal plane than in Gi, some OHCs removed. Recording electrode visible patched onto a type II SGN dendrite. Giii. Same view as Gii, dendrite highlighted blue. Giv. Confocal image of a single type II SGN recording dendrite from which patch-clamp recordings were made, filled with AlexaFluor 488 hydrazide (green). Arrowhead indicates tracer artifact at recording site. White arrows indicate OHC rows. Red arrows indicate dendrite branches. DAPI in blue labels nuclei. (F-G from Weisz et al., 2009, Nature, with permission).

Glutamate has been detected in the cochlea via biochemical techniques (Godfrey et al., 1976) and implicated in IHC-type I SGN transmission by excitotoxic lesion experiments (Pujol et al., 1985). Additionally, there is histological evidence of the glutamate-aspartate transporter (GLAST) in supporting cells surrounding the IHCs and type I SGNs (Furness and Lawton, 2003; Furness and Lehre, 1997; Glowatzki et al., 2006). AMPA receptors, composed of tetramers of the subunits GluA1–4, have been found in type I SGNs (reviewed in Reijntjes and Pyott, 2016). Whole-cell patch clamp recordings from type I SGN boutons provide functional evidence of glutamatergic signaling between IHCs and type I SGNs mediated by AMPA receptors (Figure 1C, D) (Glowatzki and Fuchs, 2002). Mice lacking pre-synaptic vesicle loading of glutamate due to knockout (KO) of the vesicular glutamate transporter (VGLUT3) are protected from noise-induced loss of pre-synaptic ribbons or post-synaptic AMPA receptors (Kim et al., 2019). This finding supports the hypothesis that glutamate excitotoxicity is critical for noise-induced loss of IHC-type I SGN synapses, and likely also loss of SGN somata (reviewed in Pujol and Puel, 1999). The presence of the GluA2 subunit renders AMPA receptors calcium-impermeable (Eybalin et al., 2004), and AMPA receptors both containing and lacking GluA2 are present at mature type I SGN synapses (Hu et al., 2020; Sebe et al., 2017). The presence of GluA2-lacking AMPA receptors has not been determined at the immature type I SGN synapse. Blockade of GluA2-lacking AMPA receptors is protective against synapse loss due to noise trauma (Hu et al., 2020), which indicates that calcium entry through the calcium-permeable AMPA receptors likely mediates excitotoxic and noise-induced damage to SGNs.

Synaptic transmission through NMDA-type glutamate receptors is likely present in the cochlea, but the many contradictory data complicate efforts to detail NMDA-mediated glutamate signaling. Recordings from single, isolated spiral ganglion somata in the guinea pig (Ruel et al., 1999), or the type I SGN postsynaptic bouton in the rat (Glowatzki and Fuchs, 2002), did not show evidence that NMDA receptors substantially contributed to synaptic transmission. However, NMDA receptors are present in SGNs (Knipper et al., 1997; Lu et al., 2011; Ruel et al., 2008) and co-application of glutamate and salicylate leads to increased SGN excitability that can be prevented by NMDA antagonists. This suggests that secondary compounds can augment the response of NMDA receptors to glutamate released by IHCs (Ruel et al., 2008). More recent recordings from SGN somata suggest that NMDA receptors are critical for pre-hearing SGN maintenance (Zhang-Hooks et al., 2016). NMDA receptors may also play a role in development and synaptic repair (Ruel et al., 2007).

Similarly, kainate receptors do not appear to contribute to afferent activity (Martinez-Monedero et al., 2016; Ruel et al., 2000) or shape spontaneous excitatory post-synaptic currents (EPSCs) in vitro (Glowatzki and Fuchs, 2002). However, all five KAR subunits (GluK1–5) have been detected in afferent dendrites co-localized with GluA2 (Peppi et al., 2012)(Figure 1A, B). The compound action potential (CAP) can be reduced by cochlear perfusion of a GluK1 antagonist (Peppi et al., 2012). Post-synaptic KARs containing GluK5 and 2 have been reported at the adult IHC to type I afferent synapse, and GluK2 is also reported pre-synaptically (Fujikawa et al., 2014). No specific functional role for kainate receptors has been confirmed at the IHC-type I SGN synapse, but it is suggested that the pre-synaptic receptors could modulate neurotransmitter release, and that the post-synaptic receptors likely regulate neuronal excitability (Figure 1E) (Fujikawa et al., 2014).

The metabotropic glutamate receptor (mGluR) family consists of eight members in three groups (Lu, 2014). SGNs of guinea pig and rat express mGluR1 (Safieddine and Eybalin, 1995) and a subset show mGluR1 immunolabeling (Peng et al., 2004b). Group I (which includes mGluR1 and mGluR5) agonists induce transient inward currents (Peng et al., 2004b) and evoke action potentials (Kleinlogel et al., 1999; Peng et al., 2004b) in type I SGNs, which can be blocked by mGluR1 antagonists (Kleinlogel et al., 1999). Blocking mGluR1s in vivo had no effect on hearing threshold, but did cause a reduction in both CAP amplitude in response to loud sounds and noise-induced threshold shifts, suggesting that mGluR1 enhances cochlear responses (Peng et al., 2004b). mGluR1 has been implicated in enhancing the acetylcholine (ACh)-induced inhibition of IHCs by the transient medial olivocochlear (MOC) efferent innervation that occurs prior to hearing onset (see below), suggesting that it may also affect maturation of the ascending auditory pathway (Ye et al., 2017). Non-specific group II (mGluR2 and 3) agonists have been reported to increase dopamine release in the guinea pig cochlea via a disinhibitory mechanism in which glutamate activates mGluR2 on GABAergic, but not dopaminergic, lateral olivocochlear (LOC) efferent terminals, inhibiting tonic GABA release and thus disinhibiting dopamine release (Doleviczényi et al., 2005). This would suggest a role for mGluR2 in self-regulation of glutamate signaling via an increase in inhibitory dopamine signaling through the LOC system. However, mGluR2 has not yet been definitively localized to LOC fibers. Also, it is unclear how this mechanism would function in species in which there do not appear to be cytochemical GABAergic subgroups of LOC neurons, such as the mouse, in which all cochlear LOC fibers appear to express GABAergic markers (Maison et al., 2003a). Expression of one of the group III mGluRs, mGluR7, has been observed in IHCs, outer hair cells (OHCs) and SGNs of mice and humans (Friedman et al., 2009). Genetic variants of group III receptors have been associated with age-related hearing loss in humans (Friedman et al., 2009; Newman et al., 2012). Immunolabeling for mGluR7 localizes to efferent terminals beneath OHCs, suggesting a potential pre-synaptic role in MOC neurons (Figure 1A) (Fujikawa et al., 2014) that may inhibit neurotransmitter release via activation of Gi/Go G-proteins.

Glutamate release from OHCs

The role of OHCs in cochlear amplification is well described (Ashmore et al., 2010; Dallos, 2008), however the function of their afferent innervation of type II SGNs (Figure 1E) is unclear. The uncertainty of whether OHCs signal to type II SGNs, and if so, which neurotransmitter they use has been resolved, but the response of the type II SGNs indicates a fundamentally different function to their type I SGN counterparts.

OHCs display pre-synaptic vesicles at ribbon synapses (reviewed in Fuchs and Glowatzki, 2015), and patch-clamp capacitance recordings from immature OHCs demonstrated calcium-dependent vesicle fusion (Beurg et al., 2008), confirming the ability of OHCs to release neurotransmitter. Earlier patch-clamp recordings from type II SGN cell bodies demonstrated somatic glutamatergic currents (Jagger and Housley, 2003). Subsequent patch-clamp recordings from dendrites of type II SGNs proximal to synapses from OHCs identified glutamatergic EPSCs that were blocked by AMPA-type glutamate receptor antagonists (Figure 1F, G) (Weisz et al., 2009) and could be elicited by activation of single OHCs (Weisz et al., 2012). Recent work has shown with histology and patch-clamp electrophysiology that the calcium impermeable AMPA GluA2 receptor subunit is maintained at the type II SGN ribbon synapse into adulthood (Figure 1E) (Martinez-Monedero et al., 2016), despite initial reports that it was down-regulated after postnatal day (P)3 (Huang et al., 2012).

The functional effect of glutamate release from OHCs is weaker than from IHCs, eliciting a much smaller post-synaptic response in type II SGNs compared to type I SGNs (Figure 1D, F), despite the larger numbers of OHCs synapsing onto a type II SGN. This suggests divergent roles for type I and type II SGNs. The IHC-type I SGN synapse has large, fast post-synaptic responses that evoke action potentials with a high probability (Rutherford et al., 2012; Yi et al., 2010) to encode sound stimuli with high precision. In contrast, the OHC-type II SGN synapse is weaker. Type II SGNs may instead integrate stimuli over time or sound frequencies, and in response to loud, damaging sounds that activate the entire pool of presynaptic OHCs (reviewed in (Fuchs and Glowatzki, 2015)). Recent work demonstrates type II SGN activation by broadband sound at non-traumatic intensity levels, via glutamate release from OHCs (Weisz et al., 2021), which is consistent with activation of type II SGN by a large region of the basilar membrane. Therefore, type II SGNs likely participate in hearing during normal, non-damaging sound exposure.

Histological techniques suggest additional complexity of OHC glutamate release. Kainate receptors have been detected on type II SGNs, OHCs, and MOC efferent terminals (Figure 1E) (Fujikawa et al., 2014). This suggests varied kinetics of glutamatergic PSCs in type II SGN dendrites, although slower PSCs indicative of kainate receptor-mediated currents have not been detected (Martinez-Monedero et al., 2016). The kainate receptors on MOC terminals and OHCs suggests potential roles at both cells for glutamate spillover from the OHC-type II SGN afferent synapse. In addition, immunolabeling for the scaffolding protein Homer, associated with mGluRs (Boeckers, 2006), suggests mGluR activity at type II SGNs (Figure 1E) but at the ribbon-less, “silent” contacts adjacent to and in the same neuron as ribbon-associated contacts (Martinez-Monedero et al., 2016). The function of these synapses is currently unknown, but the “silent” contacts have been suggested as a potential substrate for synaptic plasticity.

Acetylcholine

The olivocochlear efferent neurons of the ventral brainstem innervate cells of the organ of Corti (Frank and Goodrich, 2018; Warr and Guinan, 1979), with roles in attention, adjusting cochlear gain, and protection against noise trauma via inhibition of OHC electromotility (Fuchs and Lauer, 2019). The loss of acetylcholinesterase (AChE) staining in de-efferented cochleae (Schuknecht et al., 1959, reviewed in Eybalin, 1993), demonstrates that olivocochlear neurons are cholinergic (Figure 2). ACh release from auditory efferents will only be discussed briefly because the innervation patterns, actions on hair cells, re-innervation of IHCs during aging, and functions in hearing have been recently reviewed (Fuchs and Lauer, 2019; Guinan, 2018).

Figure 2.

Figure 2.

Cholinergic signaling in the organ of Corti. A. Schematic of the developing IHC indicating localization of vesicular ACh and proton release, receptor subtypes, markers of ACh synthesis, and key potassium channels. Synaptoplasmic cistern depicted in the hair cell post-synaptic domain opposed to the MOC terminal (grey elongated oval). B. Voltage-clamp patch-clamp recordings at different holding potentials from a second post-natal week rat IHC showing spontaneous bi-phasic responses to MOC ACh release consisting of a fast cholinergic current/depolarization followed by a slower SK potassium current/hyperpolarization. (from Glowatzki and Fuchs, 2000 Science, with permission). C. Schematic of the mature OHC efferent synapse indicating localization of vesicular ACh and proton release, receptor subtypes, markers of ACh synthesis, and key potassium channels. Synaptoplasmic cistern depicted in the hair cell post-synaptic domain opposed to the MOC terminal (grey elongated oval). D. Voltage-clamp (top) and current-clamp (bottom) patch-clamp recordings from a second post-natal week mouse OHC showing evoked PSCs (top) and PSPs (bottom) in response to electrical shocks to MOC axons. Both traces show bi-phasic responses to MOC ACh release consisting of a fast cholinergic current/depolarization followed by a slower SK potassium current/hyperpolarization (from Ballestero et al., 2011 J. Neurosci, with permission). E. Schematic of the aged IHC efferent synapse, as in ‘A’, indicating the re-emergence of olivocochlear axon terminals (LOC vs MOC not yet defined, indicated by (?)OC. F. Voltage-clamp traces from single IHCs from dissected cochleae performed at the ages indicated. High potassium application induces a slow inward current in the IHC. High potassium simultaneously stimulates pre-synaptic olivocochlear efferent terminals to release ACh and evoke PSCs in the post-synaptic IHC of developing (P7–10) and aging (8.9–9.5 months, 11–12 months) mice. PSCs are not present in young adult (1 month) mice (from Zachary and Fuchs, 2015, J. Neurosci, with permission). G. Schematic of LOC to type I SGN synapse indicating localization of vesicular ACh and proton release, receptor subtypes, and markers of ACh synthesis.

Cholinergic signaling from MOC neurons onto developing IHCs

Immature IHCs are transiently innervated by MOC efferent neurons which release ACh, activating post-synaptic heteromeric nicotinic ACh receptors composed of both α9 (Elgoyhen et al., 1994) and α10 (Elgoyhen et al., 2001) subunits (Figure 2A) (reviewed in Elgoyhen and Katz, 2012). Whole-cell patch-clamp recordings from IHCs of prehearing mice show a prolonged increase in spontaneous release from MOC terminals in response to nicotine application. Since nicotine does not activate the α9/α10 nAChR on HCs, these results suggest the presence of pre-synaptic nAChRs that facilitate MOC signaling to IHCs upon activation with ACh (Zhang et al., 2020). The α1 ACh receptors are also expressed beginning around birth in IHCs in mice, but with a currently unknown function (Roux et al., 2016). The ion flow through α9α10 ACh receptors evokes a characteristic biphasic response consisting of depolarization via the ACh receptors followed by calcium-dependent activation of SK or BK potassium channels. The SK or BK current yields a long hyperpolarization, for a net inhibitory effect on the hair cells (Figure 1B) (reviewed in Fuchs and Lauer, 2019). IHCs can generate both evoked and spontaneous calcium action potentials (Kros et al., 1998). These action potentials can be reduced in frequency or abolished by hyperpolarization resulting from exogenous ACh application (Glowatzki and Fuchs, 2000), and evoked release of ACh from efferent terminals (Goutman et al., 2005). This suggests that efferent inhibition modulates the spiking patterns of IHCs, as shown in mice during the first postnatal week (Johnson et al., 2011b; Sendin et al., 2014), as well as the patterns of activity seen in the inferior colliculus (Babola et al., 2021). The spiking activity of juvenile IHCs causes bursts of activity in type I SGNs (Glowatzki and Fuchs, 2002; Tritsch et al., 2010, 2007) and is essential for the establishment and refinement of auditory system circuitry (Clause et al., 2014; Johnson et al., 2011; Tritsch et al., 2010, 2007; Tritsch and Bergles, 2010).

Cholinergic signaling from MOC neurons onto OHCs

MOC efferent fibers use the same mechanism described above to exert rapid inhibition on OHCs and immature IHCs (Figure 2A); gating of α9/α10 ACh receptors in the basolateral hair cell membrane that leads to a characteristic biphasic response via activation of SK or BK potassium channels by the calcium influx through the α9/α10 ACh receptor (Figure 2C) (Wersinger and Fuchs, 2011). OHCs develop this response over the first two postnatal weeks in rodents (Roux et al., 2011). The MOC reflex is proposed to inhibit cochlear amplification by OHCs via this cholinergic synapse onto OHCs (Figure 2D) (Fuchs and Lauer, 2019).

Cholinergic reinnervation of IHCs in aging

In the aging cochlea, efferent synapses onto IHCs re-emerge (Figure 2E), demonstrated by the appearance of efferent terminals making synaptic contacts with an immature morphology (Lauer et al., 2012). The C57BL/6J mice used for these studies have early-onset age-related hearing loss with degeneration of afferent synapses due to a mutation in cadherin 23 (Noben-Trauth et al., 2003; Stamataki et al., 2006), a major component of stereocilia tip-links (Siemens et al., 2004). Voltage-clamp recordings from the re-innervated IHCs confirm that the efferent synapses are cholinergic and inhibit the IHC via SK potassium channels, similar to the developing efferent synapse (Figure 2F, G) (Zachary and Fuchs, 2015). This efferent reinnervation of IHCs is coincident with several auditory pathologies including elevated ABR thresholds, fewer afferent synapses per IHC, increased OHC loss (Lauer et al., 2012) and ribbon loss (Zachary and Fuchs, 2015), though a causal relationship between the auditory pathology and re-innervation has not been determined. It is currently unknown whether the cholinergic re-innervation is from LOC or MOC fibers. It has previously been shown that C57BL/6J mice experience an age-related loss of MOC terminals contacting OHCs (Fu et al., 2010). It is then possible that after the deterioration of the MOC-OHC synapse, the MOC fibers retract back to innervate IHCs (Lauer et al., 2012). However, LOC efferents do innervate type I afferent fibers very close to the basal pole of the IHC, so in the event of lost afferent innervation, LOC fibers are ideally situated to re-target IHCs (Zachary and Fuchs, 2015). The function of the emergent efferent synapse is also unknown; it could be protective against further cochlear pathology by limiting IHC activity and subsequent excitotoxicity. The efferent fibers could also offer trophic support to remaining afferent fibers. The latter suggestion is consistent with the observation that the loss of afferent fibers in C57BL/6J mice preferentially occurs on the same side of the IHC as the efferent reinnervation (Lauer et al., 2012; Stamataki et al., 2006). Conversely, the reinnervation could be detrimental to hearing by suppressing IHC responses to normal levels of sound. Discovery of markers specific to LOC or MOC fibers will help to determine which cell type is innervating IHCs and will yield genetic tools to allow selective enhancement or elimination of reinnervation to further investigate its function.

Cholinergic signaling from LOC neurons

Somata of LOC efferent neurons projecting to the cochlea are located in the ventral brainstem within and immediately surrounding the lateral superior olive (LSO). Cholinergic markers including AChE, the synthesis enzyme choline acetyltransferase (ChAT), and the vesicular acetylcholine transporter (VAT) distinguish LOC efferent neurons from LSO principal afferent neurons that are implicated in sound localization (Darrow et al., 2007; Eybalin, 1993; Eybalin and Pujol, 1987; Felix and Ehrenberger, 1992; Maison et al., 2003a; Ruel et al., 2007; Safieddine et al., 1997; Safieddine and Eybalin, 1992; Sobkowicz and Emmerling, 1989; Vetter et al., 2007). The anatomy of LOC neurons has also been recently reviewed (Fuchs and Lauer, 2019), but it is unclear whether these anatomical groupings of LOC neurons are neurochemically distinct, as different methods describe differential expression of markers for dopamine, GABA, CGRP, enkephalins, and other neurotransmitters (see relevant sections).

Unlike in the MOC system, ACh exerts a net excitatory effect on the LOC neuron’s post-synaptic partner, the type I SGN neuron (Felix and Ehrenberger, 1992, 1982), which is attributed to the actions of muscarinic ACh receptors on type I SGN activity (Figure 2G) (Ito and Dulon, 2002; Maison et al., 2010b). The type I SGN spike initiation zone is located at the habenula perforata, which is very close (~20–40 μm) to the IHC-type I SGN synapse and has a high density of voltage-gated sodium channels to support action potential initiation (Hossain et al., 2005; Kim and Rutherford, 2016). The LOC neurons form synapses onto the type I SGN just peripheral to this region between the IHC and the habenula perforata, and so are ideally positioned to regulate type I SGN action potentials by modulating sodium channel activity or intrinsic electrical properties of the afferent fiber. In addition to receptor localization to SGN peripheral fibers post-synaptic to LOC neurons, immunohistochemistry suggests the presence of muscarinic receptors, specifically M2 mAChRs, on olivocochlear efferents in the IHC and OHC areas. This suggests that mAChRs may also play a role as pre-synaptic autoreceptors on efferent axon terminals (Maison et al., 2010b). Because LOC neurons may release a variety of neurotransmitters and peptides (described below), the effect of LOC neurons on hearing is varied and complex, causing both excitation and inhibition of various measures of cochlear function (Groff and Liberman, 2003).

GABA

Gamma-Aminobutyric acid (GABA) is the primary inhibitory neurotransmitter of the central nervous system (Roberts and Kuriyama, 1968) and as such was a potential candidate for inducing the reduction of the CAP seen upon efferent fiber stimulation (Galambos, 1956). Although acetylcholine was instead later found to be the primary neurotransmitter of the MOC system, evidence of GABA in the cochlea was found (Fex and Wenthold, 1976; Godfrey et al., 1976).

The OC efferent system is the only reported source of GABAergic input to the mammalian cochlea (Figure 3A)(Maison et al., 2009). Both LOC and MOC neurons are GABAergic with significant, and perhaps complete, overlap with cholinergic OC fibers. The broad cochlear innervation by efferent neurons and presence of receptors in multiple cell types suggests complex potential functions for GABA in the cochlea.

Figure 3.

Figure 3.

GABAergic signaling in the organ of Corti. In case of species-specific differences, data from mouse is depicted. A. Schematic of a cross section of the organ of Corti indicating localization of markers of GABA synthesis and receptors to cochlear cell types. B. Schematic of immature MOC-IHC synapse indicating localization of vesicular GABA and proton release, ACh and proton release, GABA receptors, ACh receptors, calcium channels, and potassium channels to cochlear cells. Released GABA activates presynaptic GABA B receptors resulting in inhibition of pre-synaptic voltage-gated calcium channels and inhibition of ACh release. C. Example voltage-clamp traces from an IHC from a P9-P11 mouse depicts PSCs evoked by electrical stimulation of MOC axon terminals. D. Application of the GABA B receptor agonist baclofen reduces the amplitude and release probability of ACh from MOC terminals, evoked as in C. E. Schematic of mature MOC-OHC synapse indicating localization of GABAergic signaling molecules to cochlear cells, as in ‘B’. F. Example voltage-clamp traces from an OHC from a P12-P16 mouse depicts PSCs evoked by electrical stimulation of MOC axon terminals. G. Application of the GABA B receptor antagonist CGP increases the release probability of ACh from MOC terminals, evoked as in F. (C,D,F,G from Wedemeyer et al 2013, J. Neurosci, with permission).

LOC efferent neurons are likely GABAergic and cholinergic. In guinea pig, radioactive GABA and markers of GABA and/or GABAergic activity have been localized to both lateral and medial components of the OC efferent system (Eybalin et al., 1988; Fex et al., 1986; Fex and Altschuler, 1984; Gulley et al., 1979). In the guinea pig ISB GABA- or GAD-like immunoreactivity peaks in the third turn (Eybalin et al., 1988; Fex et al., 1986; Fex and Altschuler, 1984), but is reported as appearing in the middle of the basal (Fex et al., 1986) or second turn (Fex and Altschuler, 1984), or to be present throughout all turns (Eybalin et al., 1988). In the ISB of mouse (Maison et al., 2003a; Nitecka and Sobkowicz, 1996), rat (Merchán-Pérez et al., 1993; Vetter et al., 1991), squirrel monkey (Thompson et al., 1986), and human (Schrott-Fischer et al., 2002), evidence of GABAergic innervation was localized along the whole length of the cochlear spiral.

In the OSB and specifically MOC terminals onto OHCs, GABAergic markers appear in the second cochlear turn and peak in the third turn of the guinea pig cochlea (Eybalin et al., 1988; Eybalin and Altschuler, 1990; Fex et al., 1986; Fex and Altschuler, 1984). In rat and mouse there are conflicting reports of GABA localization, with some studies finding evidence of GABAergic fibers only in the more apical turns (Merchán-Pérez et al., 1993; Vetter et al., 1991) and others reporting evidence of GABAergic fibers along the whole length of the cochlea (Dannhof et al., 1991; Maison et al., 2003a). The latter results are consistent with the patterns found in primates; both squirrel monkeys (Thompson et al., 1986) and humans (Schrott-Fischer et al., 2002) have GABAergic terminals contacting OHCs throughout all cochlear turns.

Whether GABAergic efferent fibers represent a subpopulation of the efferent system or whether GABA is found in all efferents appears to vary across species. Even in the cochlear areas of maximal GABA immunoreactivity in guinea pig, half or more of the fibers visualized in both the ISB and OSB are unstained, suggesting that GABAergic efferent fibers constitute a subpopulation of neurons (Eybalin et al., 1988; Fex et al., 1986; Fex and Altschuler, 1984). In contrast, staining of all MOC fibers or terminals has been reported in human (Schrott-Fischer et al., 2002), rat (Dannhof et al., 1991) and mouse (Maison et al., 2003a), with the latter study showing 100% co-localization of GAD and VAT staining to confirm that all cholinergic efferent MOCs co-express GABA. Interestingly, the same study found more GAD-positive terminals compared to VAT-positive terminals in LOC fibers of the apical cochlea, however this could be due to lower immunostaining intensity for VAT (Maison et al., 2003a), and still suggests that no GABAergic subgroup exists. Studies investigating additional cochlear neurotransmitters, such as dopamine and serotonin (see below), suggest that signaling between LOC neurons from different sub-populations as defined by GABA expression is critical for some aspects of these other neurotransmitters’ functions. However, these complex interactions between neurotransmitter systems may need to be reconsidered in species that may not have clear distinctions between LOC neuron subpopulations.

GABAergic signaling may play a role in development of the auditory system, with one proposed mechanism acting via GABA B receptors. GABA B receptors are G-protein coupled receptors composed of two subunits, GABA B1 and GABA B2, and are expressed in SGNs (Lin et al., 2000). The GABA B1 receptor subunit is necessary for functional GABA B receptors (Prosser et al., 2001; Schuler et al., 2001). The GABA B1 subunit is not observed in the hair cells of adult (Maison et al., 2009) or juvenile (Wedemeyer et al., 2013) mice. Instead, GABA B1 has been observed around the onset of hearing in the IHC and OHC areas in both efferent and afferent fibers, using mice expressing GFP-tagged GABA B1 subunits (Wedemeyer et al., 2013). Patch-clamp experiments were performed from either developing mouse IHCs or from OHCs shortly after hearing onset, during the stages when each hair cell type is innervated by MOC terminals (Figure 3B, E). GABA inhibits ACh release from MOC efferents at both synapses by activating presynaptic GABA B receptors located on the MOC axon terminal (Figure 3CD, FG), confirmed to contain the GB1a isoform at the IHC-MOC synapse (Wedemeyer et al., 2013). These experiments propose a physiological role for GABA in feedback inhibition of efferent transmission. In adult mice, GABA B1 Rs are no longer seen in the efferent fibers and deletion of this subunit does not affect the MOC efferent suppression of OHC activity (Maison et al., 2009). GABA signaling through the B1 receptor in efferent fibers regulates the strength of the MOC-IHC synapse in a critical developmental period (Wedemeyer et al., 2013), during which the spiking activity of IHCs is thought to drive circuit development in higher auditory nuclei (Clause et al., 2014), and so likely has a role in development of auditory circuits.

GABA signaling has been implicated in maintenance of cochlear structures through activation of both metabotropic GABA B receptors, described above, and GABA A receptors. Ionotropic GABA A receptors are ligand-gated chloride channels composed of 5 subunits with diverse receptor composition (Goetz et al., 2007). PCR experiments have identified the GABA A α1–6, β1–3 and γ2 subunits in the cochlea of (P)14–18 mice (Drescher et al., 1993). Mice with systemic knockouts of GABA A receptor subunits α1, α2, and α6 show no cochlear histopathology or auditory function deficits into adulthood (Maison et al., 2006). This suggests that these subunits are not integral for hair cell or neuron function or development, although compensation by other GABA A subunits is possible (Kralic et al., 2002). Mice with systemic knockouts of either the GABA A receptor subunits α5, β2, β3 (Maison et al., 2006), or metabotropic GABA B1 receptor subunits (Maison et al., 2009) do not initially have increased OHC loss compared to WT, but do exhibit elevations of DPOAE and ABR thresholds. The increases in threshold for both measurements were similar, suggesting dysfunction of the OHCs that impairs their role in cochlear amplification (Maison et al., 2009, 2006). As they age, the GABA A receptor α5 and β2 subunit knockout animals have ABR shifts that are significantly larger than the DPOAE shifts, suggesting a progressive dysfunction in afferent neuron or IHC function. All three GABA A receptor mutants also show progressive loss of IHCs and OHCs in the basal 15% of the cochlea, loss of afferent fibers where IHCs are also lost, and reduced efferent innervation of OHCs throughout the cochlea. In α5 and β2 subunit KO animals, efferent innervation develops normally, and its deterioration occurs at varying ages of onset depending on which receptor subunit is missing (Maison et al., 2006). The broad range of abnormalities seen in the GABA A receptor subunit knockouts suggests multiple sites of GABA action through GABA A receptors in the cochlea, and potentially distinct roles for receptors composed of different GABA A subunit complements. These results suggest roles for GABA in the long-term maintenance of both IHC and OHC, and the efferent and afferent neurons of the cochlea. However, interplay between peripheral and central circuitry may also be involved in deficits seen in GABA receptor knockout animals. The MOC synapse onto developing IHCs is critical for development of afferent circuitry (Clause et al., 2014). Further, inhibitory synapses from the ascending medial nucleus of the trapezoid body (MNTB) have been found on LOC (Sterenborg et al., 2010) and MOC neurons in the brainstem (Torres Cadenas et al., 2020), suggesting that both MOC and LOC somatic function may be disrupted by systemic GABA receptor KOs. Nonetheless, GABA receptor knockout experiments do demonstrate important roles for GABA in auditory function, cochlear morphology, and cellular maintenance.

It is currently unclear what the acute effects of GABA A receptor signaling are on hair cell function because the systemic knockouts described above affect survival of cochlear cells and possible changes to central circuitry, but studies suggest a potential for GABAergic signaling during normal hearing conditions. In adult guinea pig, α and β subunits were detected at the basal pole of isolated OHCs, but not IHCs (Plinkert et al., 1989). Hyperpolarization (Gitter and Zenner, 1992; Plinkert et al., 1993) and changes in motility (Batta et al., 2004; Plinkert et al., 1993) induced by exogenous GABA application, and blocked by GABA A antagonists, have been reported in isolated OHCs of adult guinea pigs. Diffuse immunostaining for the β2 and β3 subunits has been observed in mouse OHCs in the cochlear apex (Maison et al., 2006) but no effect of GABA is seen in OHCs (or IHCs) of dissected whole cochlear preparations of (P)9–16 mice (Wedemeyer et al., 2013). Thus, the action of GABA A receptors on OHCs is still unclear.

GABA may also play a modulatory role in SGN afferent signaling. In vivo extracellular recordings in the IHC dendritic region revealed little effect of iontophoresed GABA on the spontaneous firing rates of afferent fibers. However, GABA application inhibits ACh- or glutamate-evoked type I SGN activity (Arnold et al., 1998; Felix and Ehrenberger, 1992), likely through GABA A receptors (Arnold et al., 1998). These results suggest that GABA release may reduce auditory nerve activity but through an unknown mechanism. GABA A receptor subunit β3 immunolocalizes to SGN and subunits β2/3 also immunolocalize beneath IHCs (Maison et al., 2006), likely on type I SGN, indicating that GABA may be released from LOC axon terminals onto type I SGN peripheral processes. Indeed, whole-cell patch-clamp recordings from SGNs isolated from embryonic day (E)14-(P)5 mice display chloride currents after exogenous GABA application, which are blocked by the GABA A-specific antagonist bicuculline (Lin et al., 2000). In the guinea pig cochlea, GABA A receptors have been proposed to play a role in disinhibition pathways whereby tonic GABA release from GABAergic LOCs is inhibited by mGluR (Doleviczényi et al., 2005) or 5-HT6 /5-HT7 receptor activation (Doleviczényi et al., 2008), allowing an increase of DA release from dopaminergic LOCs. This implies that that GABA A receptors are located on a subpopulation of GABAergic LOC terminals, however, this mechanism may not apply to other species where GABAergic subgroups of LOC may not exist (Maison et al., 2003a).

GABA may also have a role in protection against noise trauma. Vulnerability to permanent, but not temporary, acoustic injury is decreased in GABA B1 KO mice suggesting that GABAergic signaling may play a role in the processes triggered by acoustic trauma. In adult mice, GABA B1 receptors are no longer immunolocalized to efferent terminals but can be immunolocalized to the synaptic terminals of both type I and type II SGN (Maison et al., 2009). This receptor localization suggests GABAergic signaling in both SGN types into adulthood, likely from the olivocochlear efferent system. However, this was a systemic knockout of the GABA B1 receptor, and developmental processes at IHCs, OHCs, or other cell types may also have been subtly altered.

Despite being demonstrated to be present in only the olivocochlear efferent system, GABA plays many roles in the cochlea which appear to be governed by careful timing and location of receptor expression as well as receptor subunit composition. GABA B receptors likely aid auditory circuitry development by inhibiting ACh release. GABA A receptors also possibly modulate the release of other neurotransmitters and have roles in the maintenance of HCs, efferent fibers, and afferent fibers. Both receptor subfamilies are involved in normal hearing function, evidenced by functional deficits after systemic KO, however future work using cell type-specific mutations or inducible knockouts may be needed to separate of the roles of GABA in peripheral vs central circuits, and in development vs the mature system.

Glycine

Glycine is one of the primary inhibitory neurotransmitters in the central nervous system and has been detected in the cochlea in numerous studies (reviewed in (Eybalin, 1993)). However, a precise role for glycine activity in the cochlea has not been determined. This is in part because the commonly used glycine receptor (GlyR) blocker strychnine is also a potent antagonist of the α9/α10 ACh receptors that mediate MOC efferent activity on hair cells (Kujawa et al., 1993; Sewell, 2011; Sridhar et al., 1995), which confounds effects. Despite this experimental limitation, more recent work indicates a possible role for glycine in cochlear efferent function using expression and protein localization studies of GlyRs and the GlyR anchoring protein gephyrin. Prior to hearing onset GlyRs localize to the base of IHCs, likely post-synaptic to MOC axon terminals that transiently innervate IHCs. After hearing onset, GlyRs localize both to the base of OHCs, likely post-synaptic to MOC axon terminals, and also to puncta below IHCs that suggest a localization on type I SGN peripheral fibers post-synaptic to LOC efferents (Buerbank et al., 2011; Dlugaiczyk et al., 2008). GlyRα2 is the predominant isoform before hearing onset and GlyRα3 is the predominant isoform after hearing onset, with some early expression of GlyRα1 (Buerbank et al., 2011). GlyRs also localize to SGN somata (Buerbank et al., 2011; Dlugaiczyk et al., 2008), and exogenous glycine evokes GlyR-mediated currents in cultured SGN somata (Sun and Salvi, 2009).

Glycine receptor knockout studies suggest glycine function in the cochlea, with possible interactions with glycinergic circuitry in the auditory brainstem. Mice with a knockout of the GlyRα3 subunit had normal wave I ABR thresholds but were more susceptible to noise trauma (Dlugaiczyk et al., 2016) and have impaired detection of signals in noise (Tziridis et al., 2017). Together these results suggest that OHCs have normal function, but that the MOC synapse onto OHCs that provides some protection against noise-induced trauma is impaired. However, the knockout of GlyRα3 in both studies was systemic and likely impaired central processing throughout the superior olivary complex (SOC). Indeed, LOC (Sterenborg et al., 2010) and MOC (Torres Cadenas et al., 2020) somata in the brainstem receive glycinergic synaptic inputs, and the GlyRα3 deficient mice also showed ABR deficits in wave III and IV suggesting aberrant signaling in the SOC (Tziridis et al., 2017). Nonetheless, GlyR localization and hearing deficits in GlyRα3 mice suggest that glycinergic signaling is implicated in MOC and possibly LOC efferent circuitry function, with potential interactions between cochlear and SOC mechanisms that have yet to be characterized.

Purines

The majority of known purine receptors are present in the cochlea, in a wide variety of cell types (reviewed in Köles et al., 2019), however the location, conditions and functional effects of purine release are not completely understood. P2X receptors are ionotropic and primarily activated by ATP (reviewed in North, 2016). P2Y receptors are metabotropic and the different subtypes are activated by the pyrimidine UTP, ATP, or the ATP metabolite ADP, alone or in combination (reviewed in von Kügelgen and Hoffmann, 2016). Purinergic receptors are localized to the organ of Corti and afferent neurons, however it is unclear whether extracellular purines in the cochlea have functions during exposure to normal levels of sound. P2X2 receptor subunits have been immunohistochemically mapped to the synaptic regions beneath OHCs and IHCs (Järlebark et al., 2000) and more specifically, to the post-synaptic density of type I and type II SGNs (Housley et al., 1999), although vesicular release of ATP from hair cells has not been documented. P2Y receptor subunits have been localized to various cells of the organ of Corti, including SGNs, which express all five subunits into adulthood (Huang et al., 2010). Exogenously applied ATP causes excitation of SGNs via two mechanisms; a direct depolarization of type I (Ito and Dulon, 2002) and type II afferent fibers (Liu et al., 2015; Weisz et al., 2009), as well as excitation of OHCs that causes them to release glutamate (Weisz et al., 2009).

The role of purines in responses to high intensity sounds have been documented. In some circumstances purine release may be protective against noise trauma; upon sound exposure, ATP levels increase in endolymph (Housley et al., 2013; Muñoz et al., 2001) and activate ionotropic P2X2 receptors in cells lining the endolymphatic space (Housley et al., 2013). P2X2 receptor activation leads to an electrical shunt as potassium diffuses out of the endolymph reducing the endocochlear potential and, in turn, cochlear sensitivity (Thorne et al., 2004). The direct excitation of OHCs by purines may also be involved in this protective response, as OHC depolarization by ATP (Nakagawa et al., 1990) renders them less responsive to sound and hinders their role in cochlear amplification (Thorne et al., 2004). Purines are also involved in cochlear responses to sounds that are loud enough to cause cellular damage. Rupturing OHCs to mimic cochlear trauma causes type II SGN depolarization mediated by both P2X and P2Y receptors (Liu et al., 2015), and P2Y receptor-mediated calcium waves are evoked in supporting cells by laser ablation of OHCs (Gale et al., 2004). Purines may also mediate the responses of type II SGN signaling to the cochlear nucleus (CN) in mice lacking cochlear glutamate release, in response to noxious sound levels (Flores et al., 2015).

Purines also have roles in the activity seen in the pre-hearing cochlea. IHCs are known to produce spontaneous calcium spikes before hearing onset (Kros et al., 1998; Marcotti et al., 2003), leading to glutamate release from the hair cells and subsequent synaptic activation of type I SGNs (Beutner and Moser, 2001; Glowatzki and Fuchs, 2002). This patterned activity has been observed in the MNTB (Tritsch et al., 2010) and the inferior colliculus (Babola et al., 2021, 2020) and is thought to drive circuit development to set the stage for later sensory input. Recent work has shown that spontaneous release of ATP from inner supporting cells (ISCs) leads to activation of P2RY1 autoreceptors on the ISCs (Babola et al., 2020). This leads to calcium spikes, chloride efflux through TMEM16A channels, and subsequent efflux of water and potassium (Wang et al., 2015). This local rise in extracellular potassium leads to depolarization of the nearby IHCs (Wang et al., 2015) and subsequent glutamate release, which induces bursting activity in SGNs (Tritsch and Bergles, 2010). While it is clear that ISCs play a role in initiating spiking in juvenile IHCs, it is not yet clear whether the specific pattern of activity is generated by an inhibition of continuous calcium spiking (Johnson et al., 2011a) or external stimulation of the IHCs (Babola et al., 2020; Wang et al., 2015) (reviewed in Wang and Bergles, 2015).

While purinergic signaling is implicated in cochlear damage and development of auditory pathways, identification of ATP as a neurotransmitter is ambiguous due to the lack of defined pre-synaptic release. However, the full spectrum of purinergic release and signaling is likely incompletely characterized, including the potential for co-release with other neurotransmitters.

Catecholamines

Dopamine

Dopamine (DA) markers have been localized to components of the afferent and efferent systems in the cochlea (Figure 4A). Localization of dopaminergic markers to LOC neurons (Figure 4B), which are characterized as primarily cholinergic, has been well documented (see Gil-Loyzaga, 1995; Lendvai et al., 2011 for reviews). LOC neurons can be separated into two distinct groups based on the location of their somata and their innervation of the cochlea. The somata of ‘shell’ neurons are found in the area surrounding the LSO (Vetter and Mugnaini, 1992) and their axons generally bifurcate upon entry to the organ of Corti (Warr et al., 1997). The somata of ‘intrinsic’ neurons are found within the LSO, and their axons tend to travel in one direction along the organ of Corti (Warr et al., 1997).

Figure 4.

Figure 4.

Dopaminergic signaling in the organ of Corti. A. Schematic of a cross section of the organ of Corti indicating localization of dopamine receptors, transporters, and markers of dopamine synthesis to cochlear cells in the mature mammal. B. Schematic depicting the LOC-type I SGN synapse, indicating localization of vesicular dopamine and proton release, dopamine transporters, and receptors. C. Black trace: Spike train from a cultured type I SGN afferent showing action potentials evoked by 10 Hz, 150 pA sinusoidal current injection in control conditions. Red trace: Spike train from a type I SGN depicting inhibition of action potentials evoked by 10 Hz, 150 pA sinusoidal current injection following application of 100 μM dopamine, demonstrating reduced action potential amplitude and frequency following dopamine treatment (from Valdés-Baizabal 2015, PLOS One, with permission).

In mice, a subset of LOC efferent fibers that likely correspond predominantly to ‘shell’ neurons label for the dopamine synthesis enzyme tyrosine hydroxylase (TH) and not for ACh. Only a small proportion of the ‘intrinsic’ LOC fibers within the LSO are TH positive (Darrow et al., 2006). However, in guinea pig and rat, dopaminergic and cholinergic markers show almost complete co-localization, suggesting a single population of DA- and ACh-positive fibers (Safieddine et al., 1997).

Gene expression of all 5 DA receptors has been detected in the modiolar tissue of adult rats using PCR (Inoue et al., 2006), and D2 and D3 receptors have been detected in whole cochlea samples of adult mice using qPCR (Karadaghy et al., 1997). RT-PCR analysis on whole adult mouse cochleae showed higher expression levels for D2 receptors compared to D1, D5 and D4 receptors, and in contrast to above results, found no expression of D3 receptors in pre-hearing or mature mice (Maison et al., 2012). Also in mice, individual KO of DA receptors 1–5 did not cause abnormalities in gross cochlear morphology. D3–5 receptor KOs did not have changes in ABR or DPOAE thresholds, indicating no functional effects of these receptor knockouts. However, D1 and D2-nulls did have mildly altered auditory function in opposite directions: in D1 mutants, ABR and DPOAE responses were slightly enhanced, while in D2 mutants they were slightly attenuated (Maison et al., 2012). Of note, D2-antagonists raise CAP threshold in guinea pigs (Wang et al., 2014) but application of dopamine (Ruel et al., 2001), D2/3 DA receptor agonists (D’Aldin et al., 1995a, 1995b) and D1/5 agonists (Garrett et al., 2011) leads to a reduction in CAP amplitude. The reason for the discrepancies between studies of D2 receptor pharmacology have not been determined, but these results suggest that DA can dynamically regulate normal hearing function.

Studies of dopamine receptors indicate direct action on SGNs (Figure 4C). SGNs of the rat show immunoreactivity of all five DA receptor types (Inoue et al., 2006). In mice, D1 and D2 receptors have been immunolocalized to the ISB, closely associated with OC terminals, and to type I SGNs near the region of the first node of Ranvier (Maison et al., 2012). In keeping with these findings, in vivo cochlear perfusion of dopamine has been shown to reduce spontaneous and sound-driven activity of type I afferent fibers (Ruel et al., 2001), as does pharmacological inhibition of the dopamine transporter (DAT), which is responsible for the reuptake of DA from the synaptic cleft (Ruel et al., 2006). Whole-cell patch-clamp recordings from cultured rat SGNs show that DA receptor activation leads to a reduction in sodium current amplitude, causing a reduction in SGN excitability. This reduction in sodium current amplitude is the result of phosphorylation of voltage-gated sodium channels through both D1 and D2 mediated pathways acting via the Gαs/AC/cAMP/PKA and Gαq/PLC/PKC pathways, respectively (Valdés-Baizabal et al., 2015). Activation of the D1 receptor has also been shown to lead to phosphorylation of GluA1-containing AMPA receptors via PKA (Niu and Canlon, 2006), suggesting that dopamine may act on type I SGNs through second messenger cascades. Recordings from type I afferent boutons in post-hearing onset rats found that dopamine application significantly reduces spike rates in ANFs. EPSC amplitude and charge are reduced in the presence of DA and likely lead to the reduction of APs (Wu et al., 2020). Interestingly, application of dopamine also reduces the rate of release from IHCs, suggesting that DA acts pre- as well as post-synaptically to reduce ANF firing (Wu et al., 2020).

Dopaminergic modulation of auditory nerve activity may play a role in protection against excitotoxic injury as application of the D2/D3 agonist piribedil has also been shown to reduce the swelling seen in type I afferent terminals induced by periods of ischemia (D’Aldin et al., 1995b, 1995a) or acoustic trauma (D’Aldin et al., 1995b). In guinea pig, sound pre-conditioning leads to increased TH expression in LOC neurons and protects against ABR shifts generated by acoustic trauma, an effect that is blocked when TH expression is disrupted (Niu and Canlon, 2002). However, acoustic trauma alone causes a decrease in TH expression in the LOC fibers of the cochlea (Niu and Canlon, 2002) as well as LOC somata located in the LSO and the surrounding dorsolateral periolivary nucleus (Niu et al., 2004). Conversely, in mice it has been shown that noise trauma that increases ABR thresholds can induce TH expression in ‘intrinsic’ LOC neurons that were TH-negative prior to noise exposure. Both the ABR threshold shift and induced TH expression partially recover to control levels after three weeks (Wu et al., 2020). Together these findings suggest that acoustic experience can dynamically regulate dopaminergic input to auditory nerve fibers (Wu et al., 2020), but leave unresolved the discrepancies seen between LOC subgroups and responses to acoustic trauma between the two species.

Mice with specific dopamine receptor KOs also support a protective role for DA in the cochlea. Mice lacking D4 or D5 receptors show an increased shift in ABR, but not DPOAE thresholds in response to exposure to loud sounds, suggesting that these receptor types offer protection against noise trauma at the level of the type I afferent fibers. Interestingly, D2 KO mice show an increased shift in both ABR and DPOAE thresholds, suggesting protection at the level of the OHCs (Maison et al., 2012). Expression of D1, D2 and D5 receptors in isolated OHCs of p11–13 WT mice has been shown using RT-PCR (Maison et al., 2012).

In the OSB, weak labelling for the dopamine transporter (DAT) has been found near Deiters cells (Ruel et al., 2006). Consistent with this, type II SGN dendrites were also labeled in cochleae from mice expressing Cre recombinase driven by either the TH promoter or the Drd2 dopamine receptor promoter crossed with EYFP-expressing reporter mouse lines (Vyas et al., 2019, 2017; Wu et al., 2018). However, some cells that express TH do so only transiently, and do not release dopamine (reviewed in Björklund and Dunnett, 2007; Ungless and Grace, 2012), including some type I SGN that express TH around hearing onset but do not express other makers of dopamine synthesis (Trigueiros-Cunha et al., 2003). Release of dopamine from type II SGNs, or a post-synaptic target, has not been documented.

Noradrenaline / adrenaline

The role of noradrenaline (NA) in cochlear blood flow is well described, but the localization of adrenergic receptors to the organ of Corti including neuronal processes also suggests a possible role in afferent neuron function. Adrenergic receptors (AR), specifically α1-AR, β1-AR, and β2-AR, have been immunolocalized to many structures in the cochlea. Labeling has been observed in neuronal fibers under IHCs and OHCs, SGN somata (especially in the basal turn of the cochlea), and also in Hensen and Dieters supporting cells (Khan et al., 2007). The α2-ARs have a wide distribution in the cochlea throughout organ of Corti and spiral ganglion, as well as many non-sensory regions (Cai et al., 2013). Sympathetic neurons have broad innervation in the cochlea (Maison et al., 2010a) and are the likely source of cochlear NA, but sympathetic neurons are not known to synapse on hair cells or SGNs. Exogenous NA application does not increase calcium responses in isolated OHCs (Ikeda et al., 1991). However, NA application to isolated, cultured rat SGN neurons can act via α2-ARs to decrease responses to co-applied GABA (Zha et al., 2007), suggesting that NA can modulate efferent innervation of afferent neurons. However, despite the broad expression of adrenergic receptors, mice with a knockout of the gene for DBH, a required enzyme for synthesis of adrenaline and NA, had normal cochlear function and unaltered susceptibility to acoustic trauma (Maison et al., 2010a). Thus, it is unclear if, and under what conditions, NA released from sympathetic neurons could diffuse to distant adrenergic receptors on sensory cells to impact hearing.

The role of catecholamines including dopamine and noradrenaline in the cochlea are difficult to dissect due to their likely release from cells that produce many other neuroactive substances. However, recent work has brought new attention to important roles of catecholamines in cochlear functions such as responses to noise trauma.

Serotonin

Serotonin (5-hydroxytryptamine, 5-HT), a monoamine neurotransmitter, is widely known as a mediator of depression and anxiety in the brain, as well as performing a variety of diverse functions in the gut and peripheral nervous system (Berger et al., 2009). HPLC studies have also detected serotonin in cochlear tissue. HPLC of cochlear homogenates shows a rise in 5-HT concentration in adult rat cochleae after treatment with a selective serotonin reuptake inhibitor, suggesting synaptic serotonergic activity (Vicente-Torres et al., 2003). However, concentrations as detected by HPLC were not altered by noise exposure (Gil-Loyzaga et al., 2000). An antibody against 5-HT in the cat (Gil-Loyzaga et al., 1997) and rat (Gil-Loyzaga et al., 2000) labeled efferent neurons that spiral in the ISB and project to the OSB to form en passant synapses, although the synaptic targets in the cochlea or source of the axons in the brainstem were not determined (Gil-Loyzaga et al., 2000). Serotonin receptor subtypes 1A, 1B, 2B, 2C, 3, 5B, and 6 have been detected in the mouse and rat cochlea using RT-PCR (Oh et al., 1999). Immunolabeling against the serotonin reuptake transporter (SERT) was also transiently detected in cochlear tissue of marmoset embryos (Lebrand et al., 2006). This phenomenon has been observed in other non-serotoninergic neurons which have the capacity to uptake 5-HT released from 5-HT-synthesizing neurons during gestation, but do not synthesize 5-HT themselves (Lebrand et al., 2006).

Recently, transgenic mouse lines have been used to identify subpopulations of SGNs, including those displaying markers of serotonergic signaling. A mouse line expressing the gene for green fluorescent protein (GFP) under the control of the slc6a4 (SERT) promoter (slc6a4-GFP mice) exhibit selective labeling of most type II SGNs, as well as platelets and non-neuronal cells in the stria vascularis. Slc6a-4GFP fluorescence was localized to type II SGNs in both pre-hearing and young adult hearing mice across all tonotopic regions, but with the greatest density of labeled neurons in the middle cochlear turn. Interestingly, a similar BAC transgenic mouse line expressing Cre recombinase driven by the slc6a4 promotor (slc6a4Cre) crossed to the Ai9 tdTomato reporter mouse line labeled both type I and type II SGN as well as efferent neurons (Vyas et al., 2019). However, Cre expression in transgenic mouse lines does not necessarily faithfully reproduce expression patterns of the gene of interest (Schmidt et al., 2013). This study suggests slc6a4-GFP mice as possible tools for studies of type II SGNs, and slc6a4Cre mice as tools for study of both afferent and efferent neurons, but does not demonstrate serotonin release from SGNs.

While little about the function of serotonergic signaling in the cochlea is currently known, it is potentially involved with LOC dopaminergic signaling and may have a role in cochlear protection. An antagonist for the 5-HT6 and 5-HT7 metabotropic receptors has been shown to increase the release of dopamine in the absence of electric field stimulation in a cochlear in vitro microvolume superfusion preparation. The authors speculate that this occurs through proposed 5-HT inhibition of GABA release from LOC efferent fibers (Doleviczényi et al., 2008). Systemic pretreatment with an agonist for the ionotropic 5-HT3A receptor enhances cochlear protection from noise damage in mice (Ohata et al., 2021), although this could be due to activity within the brainstem at MOC somata. Furthermore, systemic knockout of the 5-HT3A receptor increases ABR threshold shifts and loss of postsynaptic receptors after noise damage, a result that can be replicated in WT mice pretreated with a 5-HT3A antagonist (Ohata et al., 2021). Taken together, these results suggest that both metabotropic and ionotropic 5-HT receptors have a functional role in the cochlea. As many drugs targeting 5-HT receptors already exist, a deeper functional understanding of serotonin signaling in the cochlea could lead to rapid translation towards clinical therapies to treat and prevent hearing loss.

Nitric Oxide

A variety of histological techniques have localized nitric oxide (NO) signaling by revealing markers for variants of the NO synthesis enzyme nitric oxide synthase (NOS) throughout the cochlea. Type I NOS (also known as neuronal NOS or nNOS (reviewed in Förstermann and Sessa, 2012)) and Type II NOS (inducible or iNOS) have been found in the cytoplasm of, and nerve endings beneath, OHCs (Franz et al., 1996; Heinrich et al., 1997) and IHCs (Heinrich et al., 1997). Type I and Type II NOS have also been found in SGN cell bodies and fibers projecting to the cochlea as well as the brainstem, supporting cells, the lateral wall, tunnel crossing fibers, and the stria vascularis (Fessenden et al., 1994; Franz et al., 1996; Heinrich et al., 1997). NOS III (also known as epithelial NOS, eNOS (reviewed in Förstermann and Sessa, 2012)) reactivity has also been documented in the cytoplasm of OHCs (Franz et al., 1996) and IHCs (Heinrich et al., 1997), the stria vascularis, and the spiral limbus (Franz et al., 1996). Interestingly, Nos1CreER;Ai9 mice, in which cells expressing Cre driven by the NOS I promoter co-express the gene for the fluorescent reporter tdTomato, show labeling specifically in type I SGN fibers and their terminals beneath IHCs when induced at (P)10. However, labeling was not seen in hair cells or efferent fibers (Vyas et al., 2019). Cre lines can often under-report the true expression pattern of a gene (Schmidt et al., 2013) so the lack of expression of Cre in some cells in the Nos1CreER;Ai9 mouse line does not necessarily imply a true lack of expression of NOS I. Indeed, functional experiments using a non-specific NOS inhibitor support NOS activity in IHCs. Live imaging using the NO-specific dye DAF-2, along with calcium indicator dyes, showed that externally-applied ATP increases the intensity of both calcium and NO dependent fluorescence in mature guinea pig IHCs (Shen et al., 2003). Further work using similar techniques showed that NO is activated by, and then inhibits, calcium influx via a cGMP-dependent protein kinase feedback loop in mature IHCs (Shen et al., 2005) with similar findings reported in adult OHCs (Shen et al., 2006).

Later experiments suggested that NO may be involved in retrograde facilitation at the immature IHC to MOC synapse. A mechanism first discovered in the brain, retrograde facilitation describes activation of pre-synaptic terminals by “on demand” neuromodulator release from their post-synaptic targets, leading to enhanced synaptic transmission (Regehr et al., 2009). In whole-cell patch-clamp experiments from developing IHCs with transient MOC innervation, retrograde facilitation generated increased quantum content of neurotransmitter release from pre-synaptic MOC efferent terminals. This quantum content increase could be mimicked by the application of NO donors and reduced by extracellular NO scavengers. The facilitation was also enhanced by manipulations to the calcium concentration within IHCs, suggesting calcium-dependent synthesis and release of NO from IHCs (Kong et al., 2013). The efferent innervation of developing IHCs by MOC neurons has been implicated in development of ascending auditory pathways (Clause et al., 2014), including refinement of MNTB axons that in turn inhibit MOC somata in the brainstem (Torres Cadenas et al., 2020). Therefore, facilitation of MOC efferent inhibition of IHCs by NO likely has roles in development of both ascending and descending cochlear circuitry.

Neuropeptides

There are over 100 known neuropeptides serving diverse purposes throughout the central and peripheral nervous system (Russo, 2017). Several of these have been identified in the cochlear perivasculature and in sympathetic fibers in the modiolus (Eybalin, 1993). As these studies deal with the regulation of cochlear blood flow rather than neurotransmission, they are not reviewed here. Below, we instead focus on studies reporting neuropeptide neurotransmission within the cochlea and possible functions of this signaling.

Calcitonin-gene related peptide (CGRP)

Calcitonin-gene related peptide (CGRP) is a potent vasodilator and activator of sensory pain fibers (Russell et al., 2014). CGRP has long been suspected to be a modulator of neuronal activity in the mammalian cochlea. There are two nearly identical isoforms of CGRP: αCGRP, which was originally discovered in the rat thyroid and is produced through alternative splicing of the calcitonin gene (Rosenfeld et al., 1983), and βCGRP, which differs by a single amino acid residue as the alternatively-spliced product of a closely-related gene (Amara et al., 1985). Isoform specific localization of CGRP is rarely specified in inner ear literature; thus all following references to CGRP are α/β non-specific unless otherwise indicated. CGRP has been localized to the inner spiral bundle (ISB), tunnel crossing fibers, and below OHCs in various species (Eybalin, 1993), including guinea pig (Cabanillas and Luebke, 2002; Qi et al., 2004), rat (Vetter et al., 1991), mouse (Maison et al., 2003b, 2003a; Nitecka and Sobkowicz, 1996; Wu et al., 2018), hamster (Simmons et al., 1996b) and human (Kong et al., 2002; Schrott-Fischer et al., 2007). EM studies show immunostaining for CGRP in the LOC fiber varicosities contacting type I SGNs, and in the MOC terminals under OHCs in multiple species (reviewed in Eybalin, 1993). Interestingly, this labeling has not been found in humans (Kong et al., 2002; Schrott-Fischer et al., 2007). CGRP expression in the MOC fibers of hamsters is present only in the apex, while there is no tonotopy to the expression in LOCs (Simmons et al., 1996a). In a CGRP-EYFP knock-in mouse line, there is a tonotopic gradient of EYFP fluorescence in type II SGN dendrites of young adult mice (Wu et al., 2018). However, as genetic reporter expression does not always faithfully reproduce endogenous expression of a gene of interest (Schmidt et al., 2013), complementary experiments are needed to unequivocally conclude the presence of the peptide in type II SGNs. CGRP reactivity has been found in supporting cells of the human (Kong et al., 2002) and guinea pig (Qi et al., 2004) as well as in the guinea pig stria vascularis and osseous spiral lamina (Qi et al., 2004).

In vivo evidence for CGRP as a cochlear neuromodulator comes from experiments with αCGRP knockout mice. These mice, which also lack βCGRP, have normal ABR and DPOAE thresholds but decreased suprathreshold wave 1 ABR amplitudes. These results suggest normal cochlear mechanics and OHC function, but impaired transmission at the IHC-type I SGN synapse (Maison et al., 2003b). Given the location of the impairment and the demonstrated presence of CGRP in the LOC efferent system, it is possible that CGRP released from LOC efferent neurons exerts a selective, post-synaptic effect on type I SGNs (Maison et al., 2003b; Safieddine et al., 1997). However, the mechanism of synaptic dysfunction in the type I SGNs of αCGRP knockout mice is unknown. Defining a role for CGRP in the organ of Corti distinct from its roles in supporting cells, stria vascularis, and vasculature requires further investigation.

Substance P

Early work found conflicting evidence of the presence of substance P in the various components of the lower auditory system. Substance P was reported in the cochlea based on radioimmunoassay (Nowak et al., 1990). However, different findings on localization were reported both within and across species. In some guinea pig studies, no evidence was found of immunolabeling for substance P in the organ of Corti, spiral ganglion, auditory nerve, or cochlear nucleus (Davies, 1982). Yet in other guinea pig studies, findings included immunostaining of cochlear hair cells and weak immunostaining in the SG (Nowak et al., 1986), immunoreactivity in OHC and IHC areas (Schickinger et al., 1996), and immunoreactivity in neural elements beneath IHCs with occasional SG somatic labeling (Ylikoski et al., 1989). In rabbit, ~50% of basal spiral ganglion cells were found to show substance P-like immunoreactivity, but no immunoreactivity was seen in the organ of Corti (Ylikoski et al., 1984). In human, substance P was found in all SG cells (Anniko et al., 1995).

Despite a lack of clarity on substance P localization in the cochlea, the substance P receptor, NK1 has been localized to SGNs (Sun et al., 2004), and several studies support a functional role of substance P in the cochlea. Intracochlear perfusion of the NK1 receptor agonist substance P methyl ester (SPME) caused a dose-dependent increase in the amplitude of the CAP and the negative summating potential. These effects could be blocked by the application of an antagonist of substance P and suggest a function for substance P in modulating the auditory nerve directly (Nario et al., 1995). Application of substance P to dissociated type I SGNs has multiple effects; one group has shown prolonged duration and increased latency of APs, and suppression of calcium and voltage-gated potassium currents (Sun et al., 2004). Another has shown intracellular calcium release through the G-protein coupled phospholipase-C (PLC) pathway, and activation of a non-selective cation current which depolarizes SGNs (Ito et al., 2002). Depolarization of SGNs increases excitability, and indeed, extracellular potentials recorded in vivo from the subsynaptic region of IHCs show an increase in firing rate upon substance P iontophoresis, an effect that can be blocked by the specific substance P antagonist, spantide (Schickinger et al., 1996).

In contrast to the excitation of SGNs, application of substance P to isolated guinea pig OHCs decreases a non-selective cation conductance leading to inhibition. This effect is likely mediated by a PTX-insensitive G-protein pathway (Kakehata et al., 1995, 1993), but it is not clear through which receptor this pathway is activated (Kakehata et al., 1995). Whole-cell patch-clamp recordings suggest that intracellular calcium is not necessary for this response (Kakehata et al., 1995) and this is supported by the finding that substance P fails to elicit a change in intracellular calcium levels when applied to isolated guinea pig OHCs (Ikeda et al., 1991). A decrease in a non-selective cation conductance leads to hyperpolarization of the OHCs, therefore these results suggest that substance P activity could be a means to regulate OHC electromotility.

While substance P clearly has effects on cochlear physiology through action on both SGNs and OHCs, its site of release and full range of potential actions are still unknown and warrant further investigation.

Neuropeptide Y

Though neuropeptide Y (NPY) is most often associated with regulation of blood flow in the peripheral nervous system, NPY signaling is additionally implicated in neuropsychiatric, neurologic, and homeostatic properties in the central nervous system, suggesting a direct neuromodulatory role. (Alviña et al., 2021). In the rate organ of Corti, (NPY) immunoreactivity has been found in IHCs, OHCs, pillar cells, Deiters cells, and type I and II SGNs (Gomide et al., 2009). It has also been found in a subpopulation of SGN somata (but not fibers) in humans (Anniko et al., 1995). These localization patterns suggest that cochlear NPY may also have a neuromodulatory function, rather than exclusively controlling cochlear blood flow (Eybalin, 1993). Functionally, moderate noise exposure has been reported to increase NPY expression in SGNs (Gomide et al., 2009). Given the roles of NPY in the central nervous system, perhaps cochlear release of NPY plays a role in the responses to changing cochlear energy levels or to sound-evoked trauma.

Opioid Peptides

Initial histological studies in the cochlea demonstrated markers of opioid peptides, including Met-enkephalin, with biochemical evidence for increased production following noise exposure (Eybalin, 1993). Immuno-colocalization of opioid receptors and ChAT suggested that opioid receptors are present on auditory and vestibular efferents (Eybalin et al., 1988). Later work also found opioid receptors under both IHCs and OHCs in the guinea pig and mouse cochleae (Jongkamonwiwat et al., 2006; Nguyen et al., 2014) and in the spiral ganglion of the mouse and human (Nguyen et al., 2014).

Systemic administration of opioid painkillers in rodents increases the amplitude of peak 1 in ABR recordings, while perfusion into the middle ear increases the CAP N1-P1 amplitude, indicating increased sound-evoked responses in the auditory nerve. DPOAEs were normal, suggesting that clinical opioid agonists act at the IHC-type I SGN synapse and not at OHCs (Ramírez et al., 2020). Clinically, opioid-associated hearing loss is a common comorbidity in patients with opioid use disorder, and there is one published case of a temporary (but reproducible) hearing loss after oxymorphone inhalation (MacDonald et al., 2015).

The precise mechanisms of opioid action in the cochlea are under active investigation. Opioid peptide activation of the LOC system is well reviewed elsewhere (Wersinger and Fuchs, 2011). However, activation of the α9α10 nAChR by opioid agonists makes it difficult to pharmacologically isolate opioid effects in LOC neurons (Lioudyno et al., 2002). As for individual peptides, there is some in vivo evidence that dynorphin and dynorphin-like drugs might work as inhibitory neuromodulators at the LOC-type I SGN synapse (Le Prell et al., 2014), though this result conflicts with the CAP trends mentioned above. Recently, a pathway was proposed by which dynorphins facilitate glutamate-NMDA receptor interactions, ultimately contributing to glutamate excitotoxity after prolonged noise exposure (Sahley et al., 2019, 2013).

Protons

In addition to critical roles in regulating pH, protons have been established as intercellular signaling molecules. The vacuolar ATPase on synaptic vesicles produces the pH and electrical gradients required to load neurotransmitters through vesicular transporters, yielding acidic vesicles that release protons along with neurotransmitter. Therefore, vesicular release of glutamate, GABA, glycine, acetylcholine, and monoamines also results in proton release (Figure 14) (reviewed in Hnasko and Edwards, 2012). Extracellular protons are implicated in both pre- and post-synaptic actions. Protons can inhibit pre-synaptic voltage-gated ion channels to negatively regulate subsequent neurotransmitter release. This is especially apparent at highly active synapses that release many vesicles, and thus many protons, such as ribbon synapses in retinal bipolar cells (Palmer et al., 2003), vestibular hair cells (Almanza et al., 2008), and also likely cochlear IHCs. Similarly, in post-hearing gerbil and rat IHCs a transient proton-mediated block of pre-synaptic calcium currents occurs upon multivesicular release, reducing pre-synaptic neurotransmitter release (Vincent et al., 2018).

Protons also have post-synaptic functions at receptors for other neurotransmitters, as well as at proton-specific receptors. Indeed, protons released from neurotransmitter-containing vesicles are implicated in post-synaptic function in the cochlea (Soto et al., 2018). Some neurotransmitter receptors including NMDA and kainate-type glutamate receptors are inhibited by protons, while GABA A receptors have variable responses to fluctuations in pH (reviewed in Soto et al., 2018). There are numerous extracellular proton sensing molecules such as the widely-expressed acid sensing ionic channels (ASIC) which are trimeric, cation permeable, voltage-insensitive channels (reviewed in Soto et al., 2018). All four ASIC family genes encoding six channel subunits have been localized to SGNs. ASIC channels mediate proton-evoked, occasionally supra-threshold excitation and inward currents in SGNs (González-Garrido et al., 2015; Peng et al., 2004a) and vestibular afferents (Mercado et al., 2006). ASIC2 KO mice have an increased resistance to temporary, but not permanent, ABR threshold shifts after acoustic exposure, suggesting a role for protons in noise-evoked trauma (Peng et al., 2004a). ASIC3 KO animals have early age-related hearing deficits (Hildebrand et al., 2004). Thus, protons can act as traditional neurotransmitters utilizing vesicular release with activity at post-synaptic receptors, in addition to their diverse modulatory effects at both pre- and post-synaptic sites.

Neurotransmitter co-release

The above sections detail neurotransmitters described in the cochlea; however, over 200 molecules can function as neurotransmitters in the nervous system (Svensson et al., 2018) and more cochlear signaling molecules and mechanisms are likely yet to be described. In the brain, many cells utilize co-release of neurotransmitters, which is well reviewed in the CNS and PNS (Burnstock, 2004; Hnasko and Edwards, 2012; Svensson et al., 2018; Tritsch et al., 2016 and others). Dale’s Principle (which was coined by Eccles in reference to Henry Dale’s work (Eccles et al., 1954; Svensson et al., 2018; Tritsch et al., 2016)) is generally interpreted to mean that a neuron releases a single neurotransmitter. However, numerous examples of neurotransmitter co-release have altered this view. Complex mechanisms of neurotransmitter co-release include release of multiple neurotransmitters from a cell, release from the same or different axon terminals, developmentally transient co-release, non-vesicular release of diffusible compounds, dendritic release, differential modulation by activity, and pre- and post-synaptic functions of released molecules (Hnasko and Edwards, 2012; Svensson et al., 2018). Many cochlear cells likely co-release neurotransmitters, perhaps utilizing these complex mechanisms of intercellular communication.

Co-localization of markers for neurotransmitter synthesis, vesicular loading, or uptake are used to infer co-release, but functional studies are necessary for confirmation. In particular, the efferent system is likely to demonstrate complex co-release of neurotransmitters. It has a well-characterized cholinergic function (Fuchs and Lauer, 2019), yet both LOC and MOC neurons immunolabel for markers of GABA or its synthesizing enzyme GAD. MOC neurons also show co-localization for CGRP (Fex and Altschuler, 1986; Maison et al., 2006, 2003a; Wedemeyer et al., 2013). Functional release of GABA from MOC terminals has been demonstrated (Wedemeyer et al., 2013). It is still unclear whether GABA and ACh are released from the same MOC axon terminals, and whether they are co-released in response to the same stimuli in vivo.

In addition to ACh and GABA, LOC neurons express markers for several other neurotransmitters including dopamine and peptides such as enkephalins and CGRP. Peptide release from efferent terminals is likely modulated by activity on different timescales than for classic small molecule neurotransmitters because peptides are synthesized in the soma, then transported to the axon terminal in dense core vesicles instead of being synthesized in axon terminals (Boarder, 1989; Hnasko and Edwards, 2012).

Additional examples of cochlear neurotransmitter co-release are described in above sections, including demonstrated NO (Kong et al., 2013) and proton (Soto et al., 2018) release from glutamatergic IHCs. Further study will likely demonstrate additional complexity of intercellular signaling involving co-release in the cochlea.

Conclusion

Studies utilizing histology, biochemistry, pharmacology, neurophysiology, auditory function tests, and cell biology have described numerous neurotransmitters with potential functions in the cochlea, and more substances are likely to be described as the list of loosely defined neurotransmitters in the nervous system grows. Powerful new tools involving genetic isolation and manipulation of cells or synapses will add to our specific knowledge of the function of each neurotransmitter. However, it is becoming clear that neurotransmitters likely do not operate in the cochlea in isolation, and that hearing involves complex and dynamic cellular interplay both within the cochlea and bi-directionally with the brain.

Highlights.

  • Multiple neurotransmitters have been identified in the cochlea, each with diverse mechanisms of release and complex patterns of post-synaptic receptors

  • Recent studies demonstrate the functions of a broad array of neurotransmitters that have been hypothesized to exist in the cochlea

  • Cochlear neurotransmitter signaling is likely dynamic in order to encode both the precision and the complexity of acoustic stimuli

Acknowledgements:

This work supported by the Intramural Research Program of the NIH, NIDCD, Z01 DC000091 (CJCW).

Footnotes

Conflicts of Interest: The authors declare no competing financial interests

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Almanza A, Mercado F, Vega R, Soto E, 2008. Extracellular pH modulates the voltage-dependent Ca2+ current and low threshold K+ current in hair cells. Neurochem. Res. 33, 1435–41. [DOI] [PubMed] [Google Scholar]
  2. Alviña K, Jodeiri Farshbaf M, Mondal AK, 2021. Long term effects of stress on hippocampal function: Emphasis on early life stress paradigms and potential involvement of neuropeptide Y. J. Neurosci. Res. 99, 57–66. [DOI] [PubMed] [Google Scholar]
  3. Amara SG, Arriza JL, Leff SE, Swanson LW, Evans RM, Rosenfeld MG, 1985. Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science 229, 1094–7. [DOI] [PubMed] [Google Scholar]
  4. Anniko M, Arnold W, Stigbrand T, Ström A, 1995. The human spiral ganglion. ORL. J. Otorhinolaryngol. Relat. Spec. 57, 68–77. [DOI] [PubMed] [Google Scholar]
  5. Arnold T, Oestreicher E, Ehrenberger K, Felix D, 1998. GABA(A) receptor modulates the activity of inner hair cell afferents in guinea pig cochlea. Hear. Res. 125, 147–53. [DOI] [PubMed] [Google Scholar]
  6. Ashmore J, Avan P, Brownell WE, Dallos P, Dierkes K, Fettiplace R, Grosh K, Hackney CM, Hudspeth AJ, Jülicher F, Lindner B, Martin P, Meaud J, Petit C, Santos-Sacchi J, Sacchi JRS, Canlon B, 2010. The remarkable cochlear amplifier. Hear. Res. 266, 1–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Babola TA, Kersbergen CJ, Wang HC, Bergles DE, 2020. Purinergic signaling in cochlear supporting cells reduces hair cell excitability by increasing the extracellular space. Elife 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Babola TA, Li S, Wang Z, Kersbergen CJ, Elgoyhen AB, Coate TM, Bergles DE, 2021. Purinergic Signaling Controls Spontaneous Activity in the Auditory System throughout Early Development. J. Neurosci. 41, 594–612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Batta TJ, Panyi G, Szucs A, Sziklai I, 2004. Regulation of the lateral wall stiffness by acetylcholine and GABA in the outer hair cells of the guinea pig. Eur. J. Neurosci. 20, 3364–70. [DOI] [PubMed] [Google Scholar]
  10. Berger M, Gray JA, Roth BL, 2009. The expanded biology of serotonin. Annu. Rev. Med. 60, 355–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Beurg M, Safieddine S, Roux I, Bouleau Y, Petit C, Dulon D, 2008. Calcium- and otoferlin-dependent exocytosis by immature outer hair cells. J. Neurosci. 28, 1798–803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Beutner D, Moser T, 2001. The presynaptic function of mouse cochlear inner hair cells during development of hearing. J. Neurosci. 21, 4593–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Björklund A, Dunnett SB, 2007. Dopamine neuron systems in the brain: an update. Trends Neurosci. 30, 194–202. [DOI] [PubMed] [Google Scholar]
  14. Boarder MR, 1989. Presynaptic aspects of cotransmission: relationship between vesicles and neurotransmitters. J. Neurochem. 53, 1–11. [DOI] [PubMed] [Google Scholar]
  15. Boeckers TM, 2006. The postsynaptic density. Cell Tissue Res. 326, 409–22. [DOI] [PubMed] [Google Scholar]
  16. Buerbank S, Becker K, Becker C-M, Brandt N, Engel J, Knipper M, Schick B, Dlugaiczyk J, 2011. Developmental regulation of glycine receptors at efferent synapses of the murine cochlea. Histochem. Cell Biol. 136, 387–98. [DOI] [PubMed] [Google Scholar]
  17. Burnstock G, 2004. Cotransmission. Curr. Opin. Pharmacol. 4, 47–52. [DOI] [PubMed] [Google Scholar]
  18. Cabanillas LA, Luebke AE, 2002. CGRP- and cholinergic-containing fibers project to guinea pig outer hair cells. Hear. Res. 172, 14–7. [DOI] [PubMed] [Google Scholar]
  19. Cai J, Li J, Mao Y, Bai X, Xu L, Wang H, 2013. Immunohistochemical localization of α2-adrenergic receptors in the neonatal rat cochlea and the vestibular labyrinth. J. Mol. Neurosci. 51, 1010–20. [DOI] [PubMed] [Google Scholar]
  20. Clause A, Kim G, Sonntag M, Weisz CJC, Vetter DE, Rubsamen R, Kandler K, 2014. The Precise Temporal Pattern of Prehearing Spontaneous Activity Is Necessary for Tonotopic Map Refinement. Neuron 82, 822–835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. D’Aldin C, Eybalin M, Puel JL, Charachon G, Ladrech S, Renard N, Pujol R, 1995a. Synaptic connections and putative functions of the dopaminergic innervation of the guinea pig cochlea. Eur. Arch. Otorhinolaryngol. 252, 270–4. [DOI] [PubMed] [Google Scholar]
  22. D’Aldin C, Puel JL, Leducq R, Crambes O, Eybalin M, Pujol R, 1995b. Effects of a dopaminergic agonist in the guinea pig cochlea. Hear. Res. 90, 202–11. [DOI] [PubMed] [Google Scholar]
  23. Dallos P, 2008. Cochlear amplification, outer hair cells and prestin. Curr. Opin. Neurobiol. 18, 370–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Dannhof BJ, Roth G, Bruns V, Roth B, Bruns V, 1991. Anatomical mapping of choline acetyltransferase (ChAT)-like and glutamate decarboxylase (GAD)-like immunoreactivity in outer hair cell efferents in adult rats. Cell Tissue Res. 266, 89–95. [DOI] [PubMed] [Google Scholar]
  25. Darrow KN, Maison SF, Liberman MC, 2007. Selective removal of lateral olivocochlear efferents increases vulnerability to acute acoustic injury. J. Neurophysiol. 97, 1775–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Darrow KN, Simons EJ, Dodds L, Liberman MC, 2006. Dopaminergic innervation of the mouse inner ear: evidence for a separate cytochemical group of cochlear efferent fibers. J. Comp. Neurol. 498, 403–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Davies WE, 1982. The absence of substance P from guinea pig auditory structures. Arch. Otorhinolaryngol. 234, 135–7. [DOI] [PubMed] [Google Scholar]
  28. Dlugaiczyk J, Hecker D, Neubert C, Buerbank S, Campanelli D, Becker C-M, Betz H, Knipper M, Rüttiger L, Schick B, 2016. Loss of glycine receptors containing the α3 subunit compromises auditory nerve activity, but not outer hair cell function. Hear. Res. 337, 25–34. [DOI] [PubMed] [Google Scholar]
  29. Dlugaiczyk J, Singer W, Schick B, Iro H, Becker K, Becker C-M, Zimmermann U, Rohbock K, Knipper M, 2008. Expression of glycine receptors and gephyrin in the rat cochlea. Histochem. Cell Biol. 129, 513–23. [DOI] [PubMed] [Google Scholar]
  30. Doleviczényi Z, Halmos G, Répássy G, Vizi ES, Zelles T, Lendvai B, 2005. Cochlear dopamine release is modulated by group II metabotropic glutamate receptors via GABAergic neurotransmission. Neurosci. Lett. 385, 93–98. [DOI] [PubMed] [Google Scholar]
  31. Doleviczényi Z, Vizi ES, Gacsályi I, Pallagi K, Volk B, Hársing LG, Halmos G, Lendvai B, Zelles T, 2008. 5-HT6/7 receptor antagonists facilitate dopamine release in the cochlea via a GABAergic disinhibitory mechanism. Neurochem. Res. 33, 2364–2372. [DOI] [PubMed] [Google Scholar]
  32. Drescher DG, Green GE, Khan KM, Hajela K, Beisel KW, Morley BJ, Gupta AK, 1993. Analysis of gamma-aminobutyric acidA receptor subunits in the mouse cochlea by means of the polymerase chain reaction. J. Neurochem. 61, 1167–70. [DOI] [PubMed] [Google Scholar]
  33. Dulon D, Jagger DJ, Lin X, Davis RL, 2006. Neuromodulation in the spiral ganglion: shaping signals from the organ of corti to the CNS. J. Membr. Biol. 209, 167–75. [DOI] [PubMed] [Google Scholar]
  34. Eccles JC, Fatt P, Koketsu K, 1954. Cholinergic and inhibitory synapses in a pathway from motor-axon collaterals to motoneurones. J. Physiol. 126, 524–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, Heinemann S, 1994. Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79, 705–15. [DOI] [PubMed] [Google Scholar]
  36. Elgoyhen AB, Katz E, 2012. The efferent medial olivocochlear-hair cell synapse. J. Physiol. Paris 106, 47–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Elgoyhen AB, Vetter DE, Katz E, Rothlin CV, Heinemann SF, Boulter J, 2001. alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc. Natl. Acad. Sci. U. S. A. 98, 3501–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Eybalin M, 1993. Neurotransmitters and neuromodulators of the mammalian cochlea. Physiol. Rev. 73, 309–73. [DOI] [PubMed] [Google Scholar]
  39. Eybalin M, Altschuler RA, 1990. Immunoelectron microscopic localization of neurotransmitters in the cochlea. J. Electron Microsc. Tech. 15, 209–224. [DOI] [PubMed] [Google Scholar]
  40. Eybalin M, Caicedo A, Renard N, Ruel J, Puel J-L, 2004. Transient Ca2+-permeable AMPA receptors in postnatal rat primary auditory neurons. Eur. J. Neurosci. 20, 2981–9. [DOI] [PubMed] [Google Scholar]
  41. Eybalin M, Parnaud C, Geffard M, Pujol R, 1988. Immunoelectron microscopy identifies several types of GABA-containing efferent synapses in the guinea-pig organ of Corti. Neuroscience 24, 29–38. [DOI] [PubMed] [Google Scholar]
  42. Eybalin M, Pujol R, 1987. Choline acetyltransferase (ChAT) immunoelectron microscopy distinguishes at least three types of efferent synapses in the organ of Corti. Exp. brain Res. 65, 261–70. [DOI] [PubMed] [Google Scholar]
  43. Felix D, Ehrenberger K, 1992. The efferent modulation of mammalian inner hair cell afferents. Hear. Res. 64, 1–5. [DOI] [PubMed] [Google Scholar]
  44. Felix D, Ehrenberger K, 1982. The action of putative neurotransmitter substances in the cat labyrinth. Acta Otolaryngol. 93, 101–5. [DOI] [PubMed] [Google Scholar]
  45. Fessenden JD, Coling DE, Schacht J, 1994. Detection and characterization of nitric oxide synthase in the mammalian cochlea. Brain Res. 668, 9–15. [DOI] [PubMed] [Google Scholar]
  46. Fex J, Altschuler RA, 1986. Neurotransmitter-related immunocytochemistry of the organ of corti. Hear. Res. 22, 249–263. [DOI] [PubMed] [Google Scholar]
  47. Fex J, Altschuler RA, 1984. Glutamic acid decarboxylase immunoreactivity of olivocochlear neurons in the organ of Corti of guinea pig and rat. Hear. Res. 15, 123–31. [DOI] [PubMed] [Google Scholar]
  48. Fex J, Altschuler RA, Kachar B, Wenthold RJ, Zempel JM, 1986. GABA visualized by immunocytochemistry in the guinea pig cochlea in axons and endings of efferent neurons. Brain Res. 366, 106–117. [DOI] [PubMed] [Google Scholar]
  49. Fex J, Wenthold RJ, 1976. Choline acetyltransferase, glutamate decarboxylase and tyrosine hydroxylase in the cochlea and cochlear nucleus of the guinea pig. Brain Res. 109, 575–85. [DOI] [PubMed] [Google Scholar]
  50. Flores EN, Duggan A, Madathany T, Hogan AK, Márquez FG, Kumar G, Seal RP, Edwards RH, Liberman MC, García-Añoveros J, 2015. A non-canonical pathway from cochlea to brain signals tissue-damaging noise. Curr. Biol. 25, 606–612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Förstermann U, Sessa WC, 2012. Nitric oxide synthases: regulation and function. Eur. Heart J. 33, 829–37, 837a-837d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Frank MM, Goodrich LV, 2018. Talking back: Development of the olivocochlear efferent system. Wiley Interdiscip. Rev. Dev. Biol. 7, 1–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Franz P, Hauser-Kronberger C, Böck P, Quint C, Baumgartner WD, 1996. Localization of nitric oxide synthase I and III in the cochlea. Acta Otolaryngol. 116, 726–31. [DOI] [PubMed] [Google Scholar]
  54. Friedman RA, Van Laer L, Huentelman MJ, Sheth SS, Van Eyken E, Corneveaux JJ, Tembe WD, Halperin RF, Thorburn AQ, Thys S, Bonneux S, Fransen E, Huyghe J, Pyykkö I, Cremers CWRJ, Kremer H, Dhooge I, Stephens D, Orzan E, Pfister M, Bille M, Parving A, Sorri M, Van de Heyning PH, Makmura L, Ohmen JD, Linthicum FH, Fayad JN, Pearson JV, Craig DW, Stephan DA, Van Camp G, 2009. GRM7 variants confer susceptibility to age-related hearing impairment. Hum. Mol. Genet. 18, 785–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Fu B, Le Prell C, Simmons D, Lei D, Schrader A, Chen AB, Bao J, 2010. Age-related synaptic loss of the medial olivocochlear efferent innervation. Mol. Neurodegener. 5, 53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Fuchs PA, Glowatzki E, 2015. Synaptic studies inform the functional diversity of cochlear afferents. Hear. Res. 330, 18–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Fuchs PA, Lauer AM, 2019. Efferent Inhibition of the Cochlea. Cold Spring Harb. Perspect. Med. 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Fujikawa T, Petralia RS, Fitzgerald TS, Wang Y-X, Millis B, Morgado-Díaz JA, Kitamura K, Kachar B, 2014. Localization of kainate receptors in inner and outer hair cell synapses. Hear. Res. 314, 20–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Furness DN, Lawton DM, 2003. Comparative distribution of glutamate transporters and receptors in relation to afferent innervation density in the mammalian cochlea. J. Neurosci. 23, 11296–304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Furness DN, Lehre KP, 1997. Immunocytochemical localization of a high-affinity glutamate-aspartate transporter, GLAST, in the rat and guinea-pig cochlea. Eur. J. Neurosci. 9, 1961–9. [DOI] [PubMed] [Google Scholar]
  61. Galambos R, 1956. Suppression of auditory nerve activity by stimulation of efferent fibers to cochlea. J. Neurophysiol. 19, 424–37. [DOI] [PubMed] [Google Scholar]
  62. Gale JE, Piazza V, Ciubotaru CD, Mammano F, 2004. A mechanism for sensing noise damage in the inner ear. Curr. Biol. 14, 526–9. [DOI] [PubMed] [Google Scholar]
  63. Garrett AR, Robertson D, Sellick PM, Mulders WHAM, 2011. The actions of dopamine receptors in the guinea pig cochlea. Audiol. Neurootol. 16, 145–57. [DOI] [PubMed] [Google Scholar]
  64. Gil-Loyzaga P, Bartolomé V, Vicente-Torres A, Carricondo F, 2000. Serotonergic innervation of the organ of Corti. Acta Otolaryngol. 120, 128–32. [DOI] [PubMed] [Google Scholar]
  65. Gil-Loyzaga P, Bartolomé MV, Vicente-Torres MA, 1997. Serotonergic innervation of the organ of Corti of the cat cochlea. Neuroreport 8, 3519–22. [DOI] [PubMed] [Google Scholar]
  66. Gil-Loyzaga PE, 1995. Neurotransmitters of the olivocochlear lateral efferent system: with an emphasis on dopamine. Acta Otolaryngol. 115, 222–6. [DOI] [PubMed] [Google Scholar]
  67. Gitter AH, Zenner HP, 1992. gamma-Aminobutyric acid receptor activation of outer hair cells in the guinea pig cochlea. Eur. Arch. Otorhinolaryngol. 249, 62–5. [DOI] [PubMed] [Google Scholar]
  68. Glowatzki E, Cheng N, Hiel H, Yi E, Tanaka K, Ellis-Davies GCR, Rothstein JD, Bergles DE, 2006. The glutamate-aspartate transporter GLAST mediates glutamate uptake at inner hair cell afferent synapses in the mammalian cochlea. J. Neurosci. 26, 7659–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Glowatzki E, Fuchs PA, 2002. Transmitter release at the hair cell ribbon synapse. Nat. Neurosci. 5, 147–54. [DOI] [PubMed] [Google Scholar]
  70. Glowatzki E, Fuchs PA, 2000. Cholinergic synaptic inhibition of inner hair cells in the neonatal mammalian cochlea. Science 288, 2366–8. [DOI] [PubMed] [Google Scholar]
  71. Godfrey DA, Carter JA, Berger SJ, Matschinsky FM, 1976. Levels of putative transmitter amino acids in the guinea pig cochlea. J. Histochem. Cytochem. 24, 468–70. [DOI] [PubMed] [Google Scholar]
  72. Goetz T, Arslan A, Wisden W, Wulff P, 2007. GABA(A) receptors: structure and function in the basal ganglia. Prog. Brain Res. 160, 21–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Gomide VC, Laureano MR, Silveira GA, Chadi G, 2009. Neuropeptide Y in rat spiral ganglion neurons and inner hair cells of organ of corti and effects of a nontraumatic acoustic stimulation. Int. J. Neurosci. 119, 508–30. [DOI] [PubMed] [Google Scholar]
  74. González-Garrido A, Vega R, Mercado F, López IA, Soto E, 2015. Acid-Sensing Ion Channels Expression, Identity and Role in the Excitability of the Cochlear Afferent Neurons. Front. Cell. Neurosci. 9, 483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Goutman JD, Fuchs PA, Glowatzki E, 2005. Facilitating efferent inhibition of inner hair cells in the cochlea of the neonatal rat. J. Physiol. 566, 49–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Groff JA, Liberman MC, 2003. Modulation of cochlear afferent response by the lateral olivocochlear system: activation via electrical stimulation of the inferior colliculus. J. Neurophysiol. 90, 3178–200. [DOI] [PubMed] [Google Scholar]
  77. Guinan JJ, 2018. Olivocochlear efferents: Their action, effects, measurement and uses, and the impact of the new conception of cochlear mechanical responses. Hear. Res. 362, 38–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Gulley RL, Fex J, Wenthold RJ, 1979. Uptake of putative neurotransmitters in the organ of Corti. Acta Otolaryngol. 88, 177–82. [DOI] [PubMed] [Google Scholar]
  79. Heinrich UR, Maurer J, Gosepath K, Mann W, 1997. Electron microscopic localization of nitric oxide I synthase in the organ of Corti of the guinea pig. Eur. Arch. Otorhinolaryngol. 254, 396–400. [DOI] [PubMed] [Google Scholar]
  80. Hildebrand MS, de Silva MG, Klockars T, Rose E, Price M, Smith RJH, McGuirt WT, Christopoulos H, Petit C, Dahl H-HM, 2004. Characterisation of DRASIC in the mouse inner ear. Hear. Res. 190, 149–60. [DOI] [PubMed] [Google Scholar]
  81. Hnasko TS, Edwards RH, 2012. Neurotransmitter corelease: mechanism and physiological role. Annu. Rev. Physiol. 74, 225–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Hossain WA, Antic SD, Yang Y, Rasband MN, Morest DK, 2005. Where is the spike generator of the cochlear nerve? Voltage-gated sodium channels in the mouse cochlea. J. Neurosci. 25, 6857–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Housley GD, Kanjhan R, Raybould NP, Greenwood D, Salih SG, Järlebark L, Burton LD, Setz VC, Cannell MB, Soeller C, Christie DL, Usami S-I, Matsubara A, Yoshie H, Ryan AF, Thorne PR, 1999. Expression of the P2X(2) receptor subunit of the ATP-gated ion channel in the cochlea: implications for sound transduction and auditory neurotransmission. J. Neurosci. 19, 8377–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Housley GD, Morton-Jones R, Vlajkovic SM, Telang RS, Paramananthasivam V, Tadros SF, Wong ACY, Froud KE, Cederholm JME, Sivakumaran Y, Snguanwongchai P, Khakh BS, Cockayne DA, Thorne PR, Ryan AF, 2013. ATP-gated ion channels mediate adaptation to elevated sound levels. Proc. Natl. Acad. Sci. U. S. A. 110, 7494–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Hu N, Rutherford MA, Green SH, 2020. Protection of cochlear synapses from noise-induced excitotoxic trauma by blockade of Ca2+-permeable AMPA receptors. Proc. Natl. Acad. Sci. U. S. A. 117, 3828–3838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Huang L-C, Barclay M, Lee K, Peter S, Housley GD, Thorne PR, Montgomery JM, 2012. Synaptic profiles during neurite extension, refinement and retraction in the developing cochlea. Neural Dev. 7, 38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Huang LC, Thorne PR, Vlajkovic SM, Housley GD, 2010. Differential expression of P2Y receptors in the rat cochlea during development. Purinergic Signal. 6, 231–248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Ikeda K, Saito Y, Nishiyama A, Takasaka T, 1991. Effect of neuroregulators on the intracellular calcium level in the outer hair cell isolated from the guinea pig. ORL. J. Otorhinolaryngol. Relat. Spec. 53, 78–81. [DOI] [PubMed] [Google Scholar]
  89. Inoue T, Matsubara A, Maruya S, Yamamoto Y, Namba A, Sasaki A, Shinkawa H, 2006. Localization of dopamine receptor subtypes in the rat spiral ganglion. Neurosci. Lett. 399, 226–9. [DOI] [PubMed] [Google Scholar]
  90. Ito K, Dulon D, 2002. Nonselective cation conductance activated by muscarinic and purinergic receptors in rat spiral ganglion neurons. Am. J. Physiol. Cell Physiol. 282, C1121–35. [DOI] [PubMed] [Google Scholar]
  91. Ito K, Rome C, Bouleau Y, Dulon D, 2002. Substance P mobilizes intracellular calcium and activates a nonselective cation conductance in rat spiral ganglion neurons. Eur. J. Neurosci. 16, 2095–102. [DOI] [PubMed] [Google Scholar]
  92. Jagger DJ, Housley GD, 2003. Membrane properties of type II spiral ganglion neurones identified in a neonatal rat cochlear slice. J. Physiol. 552, 525–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Järlebark LE, Housley GD, Thorne PR, 2000. Immunohistochemical localization of adenosine 5’-triphosphate-gated ion channel P2X(2) receptor subunits in adult and developing rat cochlea. J. Comp. Neurol. 421, 289–301. [DOI] [PubMed] [Google Scholar]
  94. Johnson SL, Beurg M, Marcotti W, Fettiplace R, 2011a. Prestin-Driven Cochlear Amplification Is Not Limited by the Outer Hair Cell Membrane Time Constant. Neuron 70, 1143–1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Johnson SL, Eckrich T, Kuhn S, Zampini V, Franz C, Ranatunga KM, Roberts TP, Masetto S, Knipper M, Kros CJ, Marcotti W, 2011b. Position-dependent patterning of spontaneous action potentials in immature cochlear inner hair cells. Nat. Neurosci. 14, 711–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Jongkamonwiwat N, Phansuwan-Pujito P, Casalotti SO, Forge A, Dodson H, Govitrapong P, 2006. The existence of opioid receptors in the cochlea of guinea pigs. Eur. J. Neurosci. 23, 2701–11. [DOI] [PubMed] [Google Scholar]
  97. Kakehata S, Akaike N, Takasaka T, 1993. Substance P decreases the non-selective cation channel conductance in dissociated outer hair cells of guinea pig cochlea. Ann. N. Y. Acad. Sci. 707, 476–9. [DOI] [PubMed] [Google Scholar]
  98. Kakehata S, Yamamoto T, Takasaka T, Akaike N, 1995. Suppression of a nonselective cation conductance by substance P in cochlear outer hair cells. Am. J. Physiol. 269, C1185–92. [DOI] [PubMed] [Google Scholar]
  99. Karadaghy AA, Lasak JM, Chomchai JS, Khan KM, Drescher MJ, Drescher DG, 1997. Quantitative analysis of dopamine receptor messages in the mouse cochlea. Brain Res. Mol. Brain Res. 44, 151–6. [DOI] [PubMed] [Google Scholar]
  100. Khan KM, Drescher MJ, Hatfield JS, Ramakrishnan NA, Drescher DG, 2007. Immunohistochemical localization of adrenergic receptors in the rat organ of corti and spiral ganglion. J. Neurosci. Res. 85, 3000–12. [DOI] [PubMed] [Google Scholar]
  101. Kim KX, Payne S, Yang-Hood A, Li S-Z, Davis B, Carlquist J, V-Ghaffari B, Gantz JA, Kallogjeri D, Fitzpatrick JAJ, Ohlemiller KK, Hirose K, Rutherford MA, 2019. Vesicular Glutamatergic Transmission in Noise-Induced Loss and Repair of Cochlear Ribbon Synapses. J. Neurosci. 39, 4434–4447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Kim KX, Rutherford MA, 2016. Maturation of NaV and KV Channel Topographies in the Auditory Nerve Spike Initiator before and after Developmental Onset of Hearing Function. J. Neurosci. 36, 2111–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Kleinlogel S, Oestreicher E, Arnold T, Ehrenberger K, Felix D, 1999. Metabotropic glutamate receptors group I are involved in cochlear neurotransmission. Neuroreport 10, 1879–82. [DOI] [PubMed] [Google Scholar]
  104. Knipper M, Köpschall I, Rohbock K, Köpke AK, Bonk I, Zimmermann U, Zenner H, 1997. Transient expression of NMDA receptors during rearrangement of AMPA-receptor-expressing fibers in the developing inner ear. Cell Tissue Res. 287, 23–41. [DOI] [PubMed] [Google Scholar]
  105. Köles L, Szepesy J, Berekméri E, Zelles T, 2019. Purinergic Signaling and Cochlear Injury-Targeting the Immune System? Int. J. Mol. Sci. 20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Kong J-H, Zachary S, Rohmann KN, Fuchs PA, 2013. Retrograde facilitation of efferent synapses on cochlear hair cells. J. Assoc. Res. Otolaryngol. 14, 17–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Kong W-J, Scholtz AW, Kammen-Jolly K, Glückert R, Hussl B, von Cauvenberg PB, Schrott-Fischer A, 2002. Ultrastructural evaluation of calcitonin gene-related peptide immunoreactivity in the human cochlea and vestibular endorgans. Eur. J. Neurosci. 15, 487–97. [DOI] [PubMed] [Google Scholar]
  108. Kralic JE, Korpi ER, O’Buckley TK, Homanics GE, Morrow AL, 2002. Molecular and pharmacological characterization of GABA(A) receptor alpha1 subunit knockout mice. J. Pharmacol. Exp. Ther. 302, 1037–45. [DOI] [PubMed] [Google Scholar]
  109. Kros CJ, Ruppersberg JP, Rüsch A, 1998. Expression of a potassium current in inner hair cells during development of hearing in mice. Nature 394, 281–4. [DOI] [PubMed] [Google Scholar]
  110. Kujawa SG, Glattke TJ, Fallon M, Bobbin RP, 1993. Contralateral sound suppresses distortion product otoacoustic emissions through cholinergic mechanisms. Hear. Res. 68, 97–106. [DOI] [PubMed] [Google Scholar]
  111. Lauer AM, Fuchs PA, Ryugo DK, Francis HW, 2012. Efferent synapses return to inner hair cells in the aging cochlea. Neurobiol. Aging 33, 2892–902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Le Prell CG, Hughes LF, Bledsoe SC, 2014. Dynorphin release by the lateral olivocochlear efferents may inhibit auditory nerve activity: a cochlear drug delivery study. Neurosci. Lett. 571, 17–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Lebrand C, Gaspar P, Nicolas D, Hornung JP, 2006. Transitory uptake of serotonin in the developing sensory pathways of the common marmoset. J. Comp. Neurol. 499, 677–89. [DOI] [PubMed] [Google Scholar]
  114. Lendvai B, Halmos GB, Polony G, Kapocsi J, Horváth T, Aller M, Sylvester Vizi E, Zelles T, 2011. Chemical neuroprotection in the cochlea: the modulation of dopamine release from lateral olivocochlear efferents. Neurochem. Int. 59, 150–8. [DOI] [PubMed] [Google Scholar]
  115. Lin X, Chen S, Chen P, 2000. Activation of metabotropic GABAB receptors inhibited glutamate responses in spiral ganglion neurons of mice. Neuroreport 11, 957–61. [DOI] [PubMed] [Google Scholar]
  116. Lioudyno MI, Verbitsky M, Glowatzki E, Holt JC, Boulter J, Zadina JE, Elgoyhen AB, Guth PS, 2002. The alpha9/alpha10-containing nicotinic ACh receptor is directly modulated by opioid peptides, endomorphin-1, and dynorphin B, proposed efferent cotransmitters in the inner ear. Mol. Cell. Neurosci. 20, 695–711. [DOI] [PubMed] [Google Scholar]
  117. Liu C, Glowatzki E, Fuchs PA, 2015. Unmyelinated type II afferent neurons report cochlear damage. Proc. Natl. Acad. Sci. U. S. A. 112, 14723–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Lu CC, Appler JM, Houseman EA, Goodrich LV, 2011. Developmental profiling of spiral ganglion neurons reveals insights into auditory circuit assembly. J. Neurosci. 31, 10903–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Lu Y, 2014. Metabotropic glutamate receptors in auditory processing. Neuroscience 274, 429–445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. MacDonald LE, Onsrud JE, Mullins-Hodgin R, 2015. Acute Sensorineural Hearing Loss After Abuse of an Inhaled, Crushed Oxymorphone Extended-Release Tablet. Pharmacotherapy 35, e118–21. [DOI] [PubMed] [Google Scholar]
  121. Maison SF, Adams JC, Liberman MC, 2003a. Olivocochlear innervation in the mouse: immunocytochemical maps, crossed versus uncrossed contributions, and transmitter colocalization. J. Comp. Neurol. 455, 406–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Maison SF, Casanova E, Holstein GR, Bettler B, Liberman MC, 2009. Loss of GABAB receptors in cochlear neurons: threshold elevation suggests modulation of outer hair cell function by type II afferent fibers. J. Assoc. Res. Otolaryngol. 10, 50–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Maison SF, Emeson RB, Adams JC, Luebke AE, Liberman MC, 2003b. Loss of alpha CGRP reduces sound-evoked activity in the cochlear nerve. J. Neurophysiol. 90, 2941–9. [DOI] [PubMed] [Google Scholar]
  124. Maison SF, Le M, Larsen E, Lee S-K, Rosowski JJ, Thomas SA, Liberman MC, 2010a. Mice lacking adrenergic signaling have normal cochlear responses and normal resistance to acoustic injury but enhanced susceptibility to middle-ear infection. J. Assoc. Res. Otolaryngol. 11, 449–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Maison SF, Liu X-P, Eatock RA, Sibley DR, Grandy DK, Liberman MC, 2012. Dopaminergic signaling in the cochlea: receptor expression patterns and deletion phenotypes. J. Neurosci. 32, 344–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Maison SF, Liu X-PP, Vetter DE, Eatock RA, Nathanson NM, Wess J, Liberman MC, 2010b. Muscarinic signaling in the cochlea: presynaptic and postsynaptic effects on efferent feedback and afferent excitability. J. Neurosci. 30, 6751–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Maison SF, Rosahl TW, Homanics GE, Liberman MC, 2006. Functional role of GABAergic innervation of the cochlea: phenotypic analysis of mice lacking GABA(A) receptor subunits alpha 1, alpha 2, alpha 5, alpha 6, beta 2, beta 3, or delta. J. Neurosci. 26, 10315–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Marcotti W, Johnson SL, Holley MC, Kros CJ, 2003. Developmental changes in the expression of potassium currents of embryonic, neonatal and mature mouse inner hair cells. J. Physiol. 548, 383–400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Martinez-Monedero R, Liu C, Weisz C, Vyas P, Fuchs PA, Glowatzki E, 2016. GluA2-Containing AMPA Receptors Distinguish Ribbon-Associated from Ribbonless Afferent Contacts on Rat Cochlear Hair Cells. eNeuro 3, 11080–11085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Mercado F, López IA, Acuna D, Vega R, Soto E, 2006. Acid-sensing ionic channels in the rat vestibular endorgans and ganglia. J. Neurophysiol. 96, 1615–24. [DOI] [PubMed] [Google Scholar]
  131. Merchán-Pérez A, Gil-Loyzaga P, López-Sánchez J, Eybalin M, Valderrama FJ, 1993. Ontogeny of γ-aminobutyric acid in efferent fibers to the rat cochlea. Dev. Brain Res. 76, 33–41. [DOI] [PubMed] [Google Scholar]
  132. Muñoz DJ, Kendrick IS, Rassam M, Thorne PR, 2001. Vesicular storage of adenosine triphosphate in the guinea-pig cochlear lateral wall and concentrations of ATP in the endolymph during sound exposure and hypoxia. Acta Otolaryngol. 121, 10–5. [DOI] [PubMed] [Google Scholar]
  133. Nakagawa T, Akaike N, Kimitsuki T, Komune S, Arima T, 1990. ATP-induced current in isolated outer hair cells of guinea pig cochlea. J. Neurophysiol. 63, 1068–74. [DOI] [PubMed] [Google Scholar]
  134. Nario K, Kitano I, Mori N, Matsunaga T, 1995. The action of substance P methyl ester on cochlear potentials in the guinea pig. Eur. Arch. Otorhinolaryngol. 252, 42–7. [DOI] [PubMed] [Google Scholar]
  135. Newman DL, Fisher LM, Ohmen J, Parody R, Fong C-T, Frisina ST, Mapes F, Eddins DA, Robert Frisina D, Frisina RD, Friedman RA, 2012. GRM7 variants associated with age-related hearing loss based on auditory perception. Hear. Res. 294, 125–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Nguyen KD, Mowlds D, Lopez IA, Hosokawa S, Ishiyama A, Ishiyama G, 2014. Mu-opioid receptor (MOR) expression in the human spiral ganglia. Brain Res. 1590, 10–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Nitecka LM, Sobkowicz HM, 1996. The GABA/GAD innervation within the inner spiral bundle in the mouse cochlea. Hear. Res. 99, 91–105. [DOI] [PubMed] [Google Scholar]
  138. Niu X, Bogdanovic N, Canlon B, 2004. The distribution and the modulation of tyrosine hydroxylase immunoreactivity in the lateral olivocochlear system of the guinea-pig. Neuroscience 125, 725–33. [DOI] [PubMed] [Google Scholar]
  139. Niu X, Canlon B, 2006. The signal transduction pathway for the dopamine D1 receptor in the guinea-pig cochlea. Neuroscience 137, 981–90. [DOI] [PubMed] [Google Scholar]
  140. Niu X, Canlon B, 2002. Activation of tyrosine hydroxylase in the lateral efferent terminals by sound conditioning. Hear. Res. 174, 124–32. [DOI] [PubMed] [Google Scholar]
  141. Noben-Trauth K, Zheng QY, Johnson KR, 2003. Association of cadherin 23 with polygenic inheritance and genetic modification of sensorineural hearing loss. Nat. Genet. 35, 21–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. North RA, 2016. P2X receptors. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 371, 349–354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Nowak R, Dorn A, Bernstein HG, Rinne A, Scholtz HJ, Ziegler M, 1986. Immunocytochemical detection of peptides in the guinea pig cochlea. Arch. Otorhinolaryngol. 243, 36–8. [DOI] [PubMed] [Google Scholar]
  144. Nowak R, Zelck U, Rathsack R, Oehme P, Scholtz HJ, Koitschev A, Beleites B, 1990. Postnatal development of substance P in the inner ear of the guinea pig. Eur. Arch. Otorhinolaryngol. 247, 147–8. [DOI] [PubMed] [Google Scholar]
  145. Oh CK, Drescher MJ, Hatfield JS, Drescher DG, 1999. Selective expression of serotonin receptor transcripts in the mammalian cochlea and its subdivisions. Brain Res. Mol. Brain Res. 70, 135–40. [DOI] [PubMed] [Google Scholar]
  146. Ohata K, Kondo M, Ozono Y, Hanada Y, Sato T, Inohara H, Shimada S, 2021. Cochlear protection against noise exposure requires serotonin type 3A receptor via the medial olivocochlear system. FASEB J. 35, e21486. [DOI] [PubMed] [Google Scholar]
  147. Palmer MJ, Hull C, Vigh J, von Gersdorff H, 2003. Synaptic cleft acidification and modulation of short-term depression by exocytosed protons in retinal bipolar cells. J. Neurosci. 23, 11332–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Peng B-G, Ahmad S, Chen S, Chen P, Price MP, Lin X, 2004a. Acid-sensing ion channel 2 contributes a major component to acid-evoked excitatory responses in spiral ganglion neurons and plays a role in noise susceptibility of mice. J. Neurosci. 24, 10167–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Peng B-G, Li QX, Ren TY, Ahmad S, Chen SP, Chen P, Lin X, 2004b. Group I metabotropic glutamate receptors in spiral ganglion neurons contribute to excitatory neurotransmissions in the cochlea. Neuroscience 123, 221–30. [DOI] [PubMed] [Google Scholar]
  150. Peppi M, Landa M, Sewell WF, 2012. Cochlear kainate receptors. J. Assoc. Res. Otolaryngol. 13, 199–208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Plinkert PK, Gitter AH, Möhler H, Zenner HP, 1993. Structure, pharmacology and function of GABAA receptors in cochlear outer hair cells. Eur. Arch. Oto-Rhino-Laryngology 250, 351–357. [DOI] [PubMed] [Google Scholar]
  152. Plinkert PK, Möhler H, Zenner HP, 1989. A subpopulation of outer hair cells possessing GABA receptors with tonotopic organization. Arch. Otorhinolaryngol. 246, 417–422. [DOI] [PubMed] [Google Scholar]
  153. Prosser HM, Gill CH, Hirst WD, Grau E, Robbins M, Calver A, Soffin EM, Farmer CE, Lanneau C, Gray J, Schenck E, Warmerdam BS, Clapham C, Reavill C, Rogers DC, Stean T, Upton N, Humphreys K, Randall A, Geppert M, Davies CH, Pangalos MN, 2001. Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient mice. Mol. Cell. Neurosci. 17, 1059–70. [DOI] [PubMed] [Google Scholar]
  154. Pujol R, Lenoir M, Robertson D, Eybalin M, Johnstone BM, 1985. Kainic acid selectively alters auditory dendrites connected with cochlear inner hair cells. Hear. Res. 18, 145–51. [DOI] [PubMed] [Google Scholar]
  155. Pujol R, Puel JL, 1999. Excitotoxicity, synaptic repair, and functional recovery in the mammalian cochlea: a review of recent findings. Ann. N. Y. Acad. Sci. 884, 249–54. [DOI] [PubMed] [Google Scholar]
  156. Qi B, Huang X, Zhu L, Tian X, Wang J, 2004. [Distribution of calcitonin gene-related peptide in guinea pig cochlea]. Lin Chuang Er Bi Yan Hou Ke Za Zhi 18, 41–2. [PubMed] [Google Scholar]
  157. Ramírez T, Soto E, Vega R, 2020. Opioid modulation of cochlear auditory responses in the rat inner ear. Synapse 74, e22128. [DOI] [PubMed] [Google Scholar]
  158. Regehr WG, Carey MR, Best AR, 2009. Activity-dependent regulation of synapses by retrograde messengers. Neuron 63, 154–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Reijntjes DOJ, Pyott SJ, 2016. The afferent signaling complex: Regulation of type I spiral ganglion neuron responses in the auditory periphery. Hear. Res. 336, 1–16. [DOI] [PubMed] [Google Scholar]
  160. Roberts E, Kuriyama K, 1968. Biochemical-physiological correlations in studies of the gamma-aminobutyric acid system. Brain Res. 8, 1–35. [DOI] [PubMed] [Google Scholar]
  161. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM, 1983. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304, 129–35. [DOI] [PubMed] [Google Scholar]
  162. Roux I, Wersinger E, McIntosh JM, Fuchs PA, Glowatzki E, 2011. Onset of cholinergic efferent synaptic function in sensory hair cells of the rat cochlea. J. Neurosci. 31, 15092–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Roux I, Wu JS, McIntosh JM, Glowatzki E, 2016. Assessment of the expression and role of the α1-nAChR subunit in efferent cholinergic function during the development of the mammalian cochlea. J. Neurophysiol. 116, 479–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Ruel J, Bobbin RP, Vidal D, Pujol R, Puel JL, 2000. The selective AMPA receptor antagonist GYKI 53784 blocks action potential generation and excitotoxicity in the guinea pig cochlea. Neuropharmacology 39, 1959–73. [DOI] [PubMed] [Google Scholar]
  165. Ruel J, Chabbert C, Nouvian R, Bendris R, Eybalin M, Leger CL, Bourien J, Mersel M, Puel J-L, 2008. Salicylate enables cochlear arachidonic-acid-sensitive NMDA receptor responses. J. Neurosci. 28, 7313–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Ruel J, Chen C, Pujol R, Bobbin RP, Puel JL, 1999. AMPA-preferring glutamate receptors in cochlear physiology of adult guinea-pig. J. Physiol. 518 ( Pt 3, 667–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Ruel J, Nouvian R, Gervais d’Aldin C, Pujol R, Eybalin M, Puel JL, 2001. Dopamine inhibition of auditory nerve activity in the adult mammalian cochlea. Eur. J. Neurosci. 14, 977–86. [DOI] [PubMed] [Google Scholar]
  168. Ruel J, Wang J, Demêmes D, Gobaille S, Puel J-L, Rebillard G, 2006. Dopamine transporter is essential for the maintenance of spontaneous activity of auditory nerve neurones and their responsiveness to sound stimulation. J. Neurochem. 97, 190–200. [DOI] [PubMed] [Google Scholar]
  169. Ruel J, Wang J, Rebillard G, Eybalin M, Lloyd R, Pujol R, Puel J-L, 2007. Physiology, pharmacology and plasticity at the inner hair cell synaptic complex. Hear. Res. 227, 19–27. [DOI] [PubMed] [Google Scholar]
  170. Russell FA, King R, Smillie S-J, Kodji X, Brain SD, 2014. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol. Rev. 94, 1099–142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Russo AF, 2017. Overview of Neuropeptides: Awakening the Senses? Headache 57 Suppl 2, 37–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Rutherford MA, Chapochnikov NM, Moser T, 2012. Spike encoding of neurotransmitter release timing by spiral ganglion neurons of the cochlea. J. Neurosci. 32, 4773–89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Safieddine S, Eybalin M, 1995. Expression of mGluR1 alpha mRNA receptor in rat and guinea pig cochlear neurons. Neuroreport 7, 193–6. [PubMed] [Google Scholar]
  174. Safieddine S, Eybalin M, 1992. Triple Immunofluorescence Evidence for the Coexistence of Acetylcholine, Enkephalins and Calcitonin Gene-related Peptide Within Efferent (Olivocochlear) Neurons of Rats and Guineapigs. Eur. J. Neurosci. 4, 981–992. [DOI] [PubMed] [Google Scholar]
  175. Safieddine S, Prior AM, Eybalin M, Soto Prior AM, Eybalin M, Prior AM, Eybalin M, 1997. Choline acetyltransferase, glutamate decarboxylase, tyrosine hydroxylase, calcitonin gene-related peptide and opioid peptides coexist in lateral efferent neurons of rat and guinea-pig. Eur. J. Neurosci. 9, 356–67. [DOI] [PubMed] [Google Scholar]
  176. Sahley TL, Anderson DJ, Hammonds MD, Chandu K, Musiek FE, 2019. Evidence for a dynorphin-mediated inner ear immune/inflammatory response and glutamate-induced neural excitotoxicity: an updated analysis. J. Neurophysiol. 122, 1421–1460. [DOI] [PubMed] [Google Scholar]
  177. Sahley TL, Hammonds MD, Musiek FE, 2013. Endogenous dynorphins, glutamate and N-methyl-d-aspartate (NMDA) receptors may participate in a stress-mediated Type-I auditory neural exacerbation of tinnitus. Brain Res. 1499, 80–108. [DOI] [PubMed] [Google Scholar]
  178. Schickinger P, Ehrenberger K, Felix D, Heiniger-Bürki C, Imboden H, Davies WE, Felix H, 1996. Substance P in the auditory hair cells in the guinea pig. Orl 58, 121–126. [DOI] [PubMed] [Google Scholar]
  179. Schmidt EF, Kus L, Gong S, Heintz N, 2013. BAC transgenic mice and the GENSAT database of engineered mouse strains. Cold Spring Harb. Protoc. 2013, 200–206. [DOI] [PubMed] [Google Scholar]
  180. Schrott-Fischer A, Kammen-Jolly K, Scholtz A, Rask-Andersen H, Glueckert R, Eybalin M, 2007. Efferent neurotransmitters in the human cochlea and vestibule. Acta Otolaryngol. 127, 13–9. [DOI] [PubMed] [Google Scholar]
  181. Schrott-Fischer A, Kammen-Jolly K, Scholtz AW, Glückert R, Eybalin M, 2002. Patterns of GABA-like immunoreactivity in efferent fibers of the human cochlea. Hear. Res. 174, 75–85. [DOI] [PubMed] [Google Scholar]
  182. Schuknecht HF,A, C.J., Doran R, 1959. The localization of acetylcholinesterase in the cochlea. AMA. Arch. Otolaryngol. 69, 549–59. [DOI] [PubMed] [Google Scholar]
  183. Schuler V, Lüscher C, Blanchet C, Klix N, Sansig G, Klebs K, Schmutz M, Heid J, Gentry C, Urban L, Fox A, Spooren W, Jaton AL, Vigouret J, Pozza M, Kelly PH, Mosbacher J, Froestl W, Käslin E, Korn R, Bischoff S, Kaupmann K, van der Putten H, Bettler B, 2001. Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron 31, 47–58. [DOI] [PubMed] [Google Scholar]
  184. Sebe JY, Cho S, Sheets L, Rutherford MA, von Gersdorff H, Raible DW, 2017. Ca2+-Permeable AMPARs Mediate Glutamatergic Transmission and Excitotoxic Damage at the Hair Cell Ribbon Synapse. J. Neurosci. 37, 6162–6175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Sendin G, Bourien J, Rassendren F, Puel J-L, Nouvian R, 2014. Spatiotemporal pattern of action potential firing in developing inner hair cells of the mouse cochlea. Proc. Natl. Acad. Sci. U. S. A. 111, 1999–2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Sewell WF, 2011. Pharmacology and Neurochemistry of Olivocochlear Efferents, in: Ryugo D, Fay R, A.P. (Ed.), Springer Handbook of Auditory Research - Auditory and Vestibular Efferents. Springer, pp. 83–103. [Google Scholar]
  187. Shen J, Harada N, Nakazawa H, Kaneko T, Izumikawa M, Yamashita T, 2006. Role of nitric oxide on ATP-induced Ca2+ signaling in outer hair cells of the guinea pig cochlea. Brain Res. 1081, 101–12. [DOI] [PubMed] [Google Scholar]
  188. Shen J, Harada N, Nakazawa H, Yamashita T, 2005. Involvement of the nitric oxide-cyclic GMP pathway and neuronal nitric oxide synthase in ATP-induced Ca2+ signalling in cochlear inner hair cells. Eur. J. Neurosci. 21, 2912–22. [DOI] [PubMed] [Google Scholar]
  189. Shen J, Harada N, Yamashita T, 2003. Nitric oxide inhibits adenosine 5’-triphosphate-induced Ca2+ response in inner hair cells of the guinea pig cochlea. Neurosci. Lett. 337, 135–8. [DOI] [PubMed] [Google Scholar]
  190. Siemens J, Lillo C, Dumont RA, Reynolds A, Williams DS, Gillespie PG, Müller U, 2004. Cadherin 23 is a component of the tip link in hair-cell stereocilia. Nature 428, 950–5. [DOI] [PubMed] [Google Scholar]
  191. Simmons DD, Mansdorf NB, Kim JH, 1996a. Olivocochlear innervation of inner and outer hair cells during postnatal maturation: evidence for a waiting period. J. Comp. Neurol. 370, 551–62. [DOI] [PubMed] [Google Scholar]
  192. Simmons DD, Moulding HD, Zee D, 1996b. Olivocochlear innervation of inner and outer hair cells during postnatal maturation: an immunocytochemical study. Brain Res. Dev. Brain Res. 95, 213–26. [DOI] [PubMed] [Google Scholar]
  193. Sobkowicz HM, Emmerling MR, 1989. Development of acetylcholinesterase-positive neuronal pathways in the cochlea of the mouse. J. Neurocytol. 18, 209–24. [DOI] [PubMed] [Google Scholar]
  194. Soto E, Ortega-Ramírez A, Vega R, 2018. Protons as Messengers of Intercellular Communication in the Nervous System. Front. Cell. Neurosci. 12, 342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Sridhar TS, Liberman MC, Brown MC, Sewell WF, 1995. A novel cholinergic “slow effect” of efferent stimulation on cochlear potentials in the guinea pig. J. Neurosci. 15, 3667–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Stamataki S, Francis HW, Lehar M, May BJ, Ryugo DK, 2006. Synaptic alterations at inner hair cells precede spiral ganglion cell loss in aging C57BL/6J mice. Hear. Res. 221, 104–18. [DOI] [PubMed] [Google Scholar]
  197. Sterenborg JC, Pilati N, Sheridan CJ, Uchitel OD, Forsythe ID, Barnes-Davies M, 2010. Lateral olivocochlear (LOC) neurons of the mouse LSO receive excitatory and inhibitory synaptic inputs with slower kinetics than LSO principal neurons. Hear. Res. 270, 119–26. [DOI] [PubMed] [Google Scholar]
  198. Sun W, Ding D-L, Wang P, Sun J, Jin X, Salvi RJ, 2004. Substance P inhibits potassium and calcium currents in inner ear spiral ganglion neurons. Brain Res. 1012, 82–92. [DOI] [PubMed] [Google Scholar]
  199. Sun W, Salvi RJ, 2009. Brain derived neurotrophic factor and neurotrophic factor 3 modulate neurotransmitter receptor expressions on developing spiral ganglion neurons. Neuroscience 164, 1854–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Svensson E, Apergis-Schoute J, Burnstock G, Nusbaum MP, Parker D, Schiöth HB, 2018. General Principles of Neuronal Co-transmission: Insights From Multiple Model Systems. Front. Neural Circuits 12, 117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  201. Thompson GC, Cortez AM, Igarashi M, 1986. GABA-like immunoreactivity in the squirrel monkey organ of Corti. Brain Res. 372, 72–9. [DOI] [PubMed] [Google Scholar]
  202. Thorne PR, Muñoz DJB, Housley GD, 2004. Purinergic modulation of cochlear partition resistance and its effect on the endocochlear potential in the Guinea pig. J. Assoc. Res. Otolaryngol. 5, 58–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Torres Cadenas L, Fischl MJ, Weisz CJC, 2020. Synaptic Inhibition of Medial Olivocochlear Efferent Neurons by Neurons of the Medial Nucleus of the Trapezoid Body. J. Neurosci. 40, 509–525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  204. Trigueiros-Cunha N, Renard N, Humbert G, Tavares MA, Eybalin M, 2003. Catecholamine-independent transient expression of tyrosine hydroxylase in primary auditory neurons is coincident with the onset of hearing in the rat cochlea. Eur. J. Neurosci. 18, 2653–62. [DOI] [PubMed] [Google Scholar]
  205. Tritsch NX, Bergles DE, 2010. Developmental regulation of spontaneous activity in the Mammalian cochlea. J. Neurosci. 30, 1539–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Tritsch NX, Granger AJ, Sabatini BL, 2016. Mechanisms and functions of GABA co-release. Nat. Rev. Neurosci. 17, 139–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Tritsch NX, Rodríguez-Contreras A, Crins TTH, Wang HC, Borst JGG, Bergles DE, 2010. Calcium action potentials in hair cells pattern auditory neuron activity before hearing onset. Nat. Neurosci. 13, 1050–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  208. Tritsch NX, Yi E, Gale JE, Glowatzki E, Bergles DE, 2007. The origin of spontaneous activity in the developing auditory system. Nature 450, 50–5. [DOI] [PubMed] [Google Scholar]
  209. Tziridis K, Buerbank S, Eulenburg V, Dlugaiczyk J, Schulze H, 2017. Deficit in acoustic signal-in-noise detection in glycine receptor α3 subunit knockout mice. Eur. J. Neurosci. 45, 581–586. [DOI] [PubMed] [Google Scholar]
  210. Ungless MA, Grace AA, 2012. Are you or aren’t you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci. 35, 422–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  211. Valdés-Baizabal C, Soto E, Vega R, 2015. Dopaminergic modulation of the voltage-gated sodium current in the cochlear afferent neurons of the rat. PLoS One 10, e0120808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Vetter DE, Adams JC, Mugnaini E, 1991. Chemically distinct rat olivocochlear neurons. Synapse 7, 21–43. [DOI] [PubMed] [Google Scholar]
  213. Vetter DE, Katz E, Maison SF, Taranda JNJ, Turcan S, Ballestero J, Liberman MC, Elgoyhen ABNB, Boulter J, 2007. The alpha10 nicotinic acetylcholine receptor subunit is required for normal synaptic function and integrity of the olivocochlear system. Proc. Natl. Acad. Sci. U. S. A. 104, 20594–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Vetter DE, Mugnaini E, 1992. Distribution and dendritic features of three groups of rat olivocochlear neurons. A study with two retrograde cholera toxin tracers. Anat. Embryol. (Berl) 185, 1–16. [DOI] [PubMed] [Google Scholar]
  215. Vicente-Torres MA, Dávila D, Bartolomé MV, Carricondo F, Gil-Loyzaga P, 2003. Biochemical evidence for the presence of serotonin transporters in the rat cochlea. Hear. Res. 182, 43–47. [DOI] [PubMed] [Google Scholar]
  216. Vincent PFY, Cho S, Tertrais M, Bouleau Y, von Gersdorff H, Dulon D, 2018. Clustered Ca2+ Channels Are Blocked by Synaptic Vesicle Proton Release at Mammalian Auditory Ribbon Synapses. Cell Rep. 25, 3451–3464.e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. von Kügelgen I, Hoffmann K, 2016. Pharmacology and structure of P2Y receptors. Neuropharmacology 104, 50–61. [DOI] [PubMed] [Google Scholar]
  218. Vyas P, Wu JS, Jimenez A, Glowatzki E, Fuchs PA, 2019. Characterization of transgenic mouse lines for labeling type I and type II afferent neurons in the cochlea. Sci. Rep. 9, 5549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Vyas P, Wu JS, Zimmerman A, Fuchs P, Glowatzki E, 2017. Tyrosine Hydroxylase Expression in Type II Cochlear Afferents in Mice. J. Assoc. Res. Otolaryngol. 18, 139–151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Wang HC, Bergles DE, 2015. Spontaneous activity in the developing auditory system. Cell Tissue Res. 361, 65–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  221. Wang HC, Lin C-C, Cheung R, Zhang-Hooks Y, Agarwal A, Ellis-Davies G, Rock J, Bergles DE, 2015. Spontaneous Activity of Cochlear Hair Cells Triggered by Fluid Secretion Mechanism in Adjacent Support Cells. Cell 163, 1348–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  222. Wang L, Li J, Yu L, Li X, 2014. Regulation of dopamine D2 receptors in the guinea pig cochlea. Acta Otolaryngol. 134, 738–43. [DOI] [PubMed] [Google Scholar]
  223. Warr WB, Boche JB, Neely ST, 1997. Efferent innervation of the inner hair cell region: origins and terminations of two lateral olivocochlear systems. Hear. Res. 108, 89–111. [DOI] [PubMed] [Google Scholar]
  224. Warr WB, Guinan JJ, 1979. Efferent innervation of the organ of corti: two separate systems. Brain Res. 173, 152–5. [DOI] [PubMed] [Google Scholar]
  225. Wedemeyer C, de San Martín Zorrilla, Ballestero J, Gómez-Casati J, Torbidoni ME, A.V., Fuchs PA, Bettler B, Elgoyhen AB, Katz E, 2013. Activation of presynaptic GABA(B(1a,2)) receptors inhibits synaptic transmission at mammalian inhibitory cholinergic olivocochlear-hair cell synapses. J. Neurosci. 33, 15477–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  226. Weisz CJC, Glowatzki E, Fuchs P, 2009. The postsynaptic function of type II cochlear afferents. Nature 461, 1126–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  227. Weisz CJC, Lehar M, Hiel H, Glowatzki E, Fuchs PA, 2012. Synaptic transfer from outer hair cells to type II afferent fibers in the rat cochlea. J. Neurosci. 32, 9528–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  228. Weisz CJC, Williams S-PG, Eckard CS, Divito CB, Ferreira DW, Fantetti KN, Dettwyler SA, Cai H-M, Rubio ME, Kandler K, Seal RP, 2021. Outer hair cell glutamate signaling through type II spiral ganglion afferents activates neurons in the cochlear nucleus in response to non-damaging sounds. J. Neurosci. (In press). [DOI] [PMC free article] [PubMed] [Google Scholar]
  229. Wersinger E, Fuchs PA, 2011. Modulation of hair cell efferents. Hear. Res. 279, 1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  230. Wichmann C, Moser T, 2015. Relating structure and function of inner hair cell ribbon synapses. Cell Tissue Res. 361, 95–114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  231. Wu JS, Vyas P, Glowatzki E, Fuchs PA, 2018. Opposing expression gradients of calcitonin-related polypeptide alpha (Calca/Cgrpα) and tyrosine hydroxylase (Th) in type II afferent neurons of the mouse cochlea. J. Comp. Neurol. 526, 425–438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  232. Wu JS, Yi E, Manca M, Javaid H, Lauer AM, Glowatzki E, 2020. Sound exposure dynamically induces dopamine synthesis in cholinergic LOC efferents for feedback to auditory nerve fibers. Elife 9, 1–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Ye Z, Goutman JD, Pyott SJ, Glowatzki E, 2017. mGluR1 enhances efferent inhibition of inner hair cells in the developing rat cochlea. J. Physiol. 595, 3483–3495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  234. Yi E, Roux I, Glowatzki E, 2010. Dendritic HCN channels shape excitatory postsynaptic potentials at the inner hair cell afferent synapse in the mammalian cochlea. J. Neurophysiol. 103, 2532–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  235. Ylikoski J, Eränkö L, Päivärinta H, 1984. Substance P-like immunoreactivity in the rabbit inner ear. J. Laryngol. Otol. 98, 759–65. [DOI] [PubMed] [Google Scholar]
  236. Ylikoski J, Pirvola U, Häppölä O, Panula P, Virtanen I, 1989. Immunohistochemical demonstration of neuroactive substances in the inner ear of rat and guinea pig. Acta Otolaryngol. 107, 417–23. [DOI] [PubMed] [Google Scholar]
  237. Zachary SP, Fuchs PA, 2015. Re-Emergent Inhibition of Cochlear Inner Hair Cells in a Mouse Model of Hearing Loss. J. Neurosci. 35, 9701–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  238. Zha D-J, Wang Z-M, Lin Y, Liu T, Qiao L, Lu L-J, Li Y-Q, Qiu J-H, 2007. Effects of noradrenaline on the GABA response in rat isolated spiral ganglion neurons in culture. J. Neurochem. 103, 57–66. [DOI] [PubMed] [Google Scholar]
  239. Zhang-Hooks Y, Agarwal A, Mishina M, Bergles DE, 2016. NMDA Receptors Enhance Spontaneous Activity and Promote Neuronal Survival in the Developing Cochlea. Neuron 89, 337–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  240. Zhang Y, Glowatzki E, Roux I, Fuchs PA, 2020. Nicotine Evoked Efferent Transmitter Release onto Immature Cochlear Inner Hair Cells. J. Neurophysiol. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES